The infection-tolerant white-footed deermouse tempers interferon responses to endotoxin in comparison to the mouse and rat

  1. Ana Milovic
  2. Jonathan V Duong
  3. Alan G Barbour  Is a corresponding author
  1. Department of Microbiology & Molecular Genetics, University of California, Irvine, United States
  2. Departments of Medicine, Microbiology & Molecular Genetics, and Ecology & Evolutionary Biology, University of California, Irvine, United States


The white-footed deermouse Peromyscus leucopus, a long-lived rodent, is a key reservoir in North America for agents of several zoonoses, including Lyme disease, babesiosis, anaplasmosis, and a viral encephalitis. While persistently infected, this deermouse is without apparent disability or diminished fitness. For a model for inflammation elicited by various pathogens, the endotoxin lipopolysaccharide (LPS) was used to compare genome-wide transcription in blood by P. leucopus, Mus musculus, and Rattus norvegicus and adjusted for white cell concentrations. Deermice were distinguished from the mice and rats by LPS response profiles consistent with non-classical monocytes and alternatively-activated macrophages. LPS-treated P. leucopus, in contrast to mice and rats, also displayed little transcription of interferon-gamma and lower magnitude fold-changes in type 1 interferon-stimulated genes. These characteristics of P. leucopus were also noted in a Borrelia hermsii infection model. The phenomenon was associated with comparatively reduced transcription of endogenous retrovirus sequences and cytoplasmic pattern recognition receptors in the deermice. The results reveal a mechanism for infection tolerance in this species and perhaps other animal reservoirs for agents of human disease.

eLife assessment

This study provides a comprehensive whole genome transcriptomic analysis of three small mammals, including Peromyscus leucopus, after exposure to endotoxin lipopolysaccharide. The authors find that the inflammatory response of the three species is complex and that P. leucopus responds differently compared to mice and rats. The data are convincing and constitute an important advance in our understanding of inflammatory responses in animals that serve as reservoirs for relevant pathogens.

eLife digest

Lyme disease is an illness caused by bacteria that spread from infected animals to humans through tick bites. While most people fully recover after a week or two of antibiotic treatments, some will continue to experience debilitating symptoms due, potentially, to the way their immune system responded to the infection.

In North America, the white-footed deermouse is one of the most common hosts of the Lyme disease bacteria. Despite its name, this rodent is more closely related to hamsters than to the mice or rats most often used in laboratory studies. Unlike mice and humans, however, deermice carrying Lyme disease bacteria do not get sick; in fact, most deermice living in a Lyme disease region will acquire the infection during their lifetimes, but it has little apparent effect on population numbers. These animals can also better tolerate infection from other microbes.

To investigate why this is the case, Milovic et al. exposed mice, rats and deermice to a bacterial toxin that triggers inflammation common to encounters with many kinds of microbes. While all species exhibited physical symptoms as a result, blood samples revealed that mice and rats, but not deermice, reacted as if they were infected with viruses as well as bacteria. This was particularly the case for interferons, a group of hormone-like proteins that protect against viruses but can also lead to harmful long-term inflammatory effects. The deermice controlled their interferon responses to the bacterial substance in a way that mice and rats could not.

Milovic et al. also checked which genes each species switched on after exposure to the toxin. This revealed that, unlike deer mice, rats and mice turned on some DNA sequences called endogenous retroviruses, which have no role in fighting infection from bacteria but can lead to harmful persistent inflammation.

These results provide elements to better understand why recovery from Lyme disease may differ between people, with some patients retaining symptoms long after their infection has abated. They could also help to better grasp why other diseases, such as COVID-19, can be followed by fatigue and other symptoms of ongoing inflammation.


How does the white-footed deermouse Peromyscus leucopus continue to thrive while sustaining infections with disease agents it serves as reservoir for (Barbour, 2017) ? The diverse tickborne pathogens (and diseases) for humans include the extracellular bacterium Borreliella burgdorferi (Lyme disease), the intracellular bacterium Anaplasma phagocytophilum (anaplasmosis), the protozoan Babesia microti (babesiosis), and the Powassan flavivirus (viral encephalitis). Most deermice remain persistently infected but display scant inflammation in affected tissues (Cook and Barbour, 2015; Long et al., 2019; Moody et al., 1994), and without apparent consequence for fitness (Schwanz et al., 2011; Voordouw et al., 2015).

A related question—conceivably with the same answer—is what accounts for the two-to-three fold longer life span for P. leucopus than for the house mouse, Mus musculus (Labinskyy et al., 2009; Sacher and Hart, 1978) ? The abundance of P. leucopus across much of North America (Hall, 1979; Moscarella et al., 2019) and its adaptation to a variety of environments, including urban areas and toxic waste sites (Biser et al., 2004; Levengood and Heske, 2008; Munshi-South and Kharchenko, 2010), indicates successful adjustment to changing landscapes and climate. Peromyscus species, including the hantavirus reservoir P. maniculatus (Morzunov et al., 1998), are more closely related to hamsters and voles in family Cricetidae than to mice and rats of family Muridae (Bradley et al., 2014).

As a species native to North America, P. leucopus is an advantageous alternative to the Eurasian-origin house mouse for study of natural variation in populations that are readily accessible (Bedford and Hoekstra, 2015; Long et al., 2022). A disadvantage for the study of any Peromyscus species is the limited reagents and genetic tools of the sorts that are applied for mouse studies. As an alternative, we study P. leucopus with a non-reductionist approach that is comparative in design and agnostic in assumptions (Balderrama-Gutierrez et al., 2021). The genome-wide expression comparison for P. leucopus is with M. musculus and, added here, the brown rat Rattus norvegicus. Given the wide range of pathogenic microbes that deermice tolerate, we use the bacterial endotoxin lipopolysaccharide (LPS) as the primary experimental treatment because the inflammation it elicits within a few hours has features common to different kinds of serious infections, not to mention severe burns and critical injuries (Xiao et al., 2011).

We previously reported that a few hours after injection of LPS, P. leucopus and M. musculus had distinguishing profiles of differentially expressed genes (DEG) in the blood, spleen, and liver (Balderrama-Gutierrez et al., 2021). In brief, the inflammation phenotype of deermice was consistent with an ‘alternatively activated’ or M2-type macrophage polarization phenotype instead of the expected ‘classically activated’ or M1-type polarization phenotype that was observed for M. musculus (Murray et al., 2014). The deermice also differed from mice in displaying evidence of greater neutrophil activation and degranulation after LPS exposure. The potentially damaging action from neutrophil proteases and reactive oxygen species appeared to be mitigated in part in P. leucopus by proteins like secretory leukocyte peptidase inhibitor, encoded by Slpi, and superoxide dismutase 2, encoded by Sod2.

Here, we first address whether the heightened transcription of neutrophil-associated genes in P. leucopus is attributable to differences in numbers of white cells in the blood. To better match for genetic diversity, we substituted outbred M. musculus for the inbred BALB/c mouse of the previous study. We retained the experimental protocol of short-term responses to LPS. This main experiment was supplemented by a study of rats under the similar conditions, by an investigation of a different dose of LPS and duration of exposure in another group of deermice, and by analysis of deermice infected with a bacterium lacking LPS. The focus was on the blood of these animals, not only because the distinctions between species in their transcriptional profiles were nearly as numerous for this specimen as for spleen and liver (Balderrama-Gutierrez et al., 2021), but also because for ecological and immunological studies of natural populations of Peromyscus species blood is obtainable from captured-released animals without their sacrifice.

The results inform future studies of Peromyscus species, not only with respect to microbial infections and innate immunity, but conceivably also determinants of longevity and resilience in the face of other stressors, such as toxic substances in the environment. The findings pertain as well to the phenomenon of infection tolerance broadly documented in other reservoirs for human disease agents, such as betacoronaviruses and bats (Mandl et al., 2018). Less directly, the results provide for insights about maladaptive responses among humans to microbes, from systemic inflammatory response syndrome to post-infection fatigue syndromes.


LPS experiment and hematology studies

Twenty adult animals each for P. leucopus and M. musculus and equally divided between sexes received by intraperitoneal injection either purified E. coli LPS at a dose of 10 µg per g body mass or saline alone (Table 1). Within 2 hr LPS-treated animals of both species displayed piloerection and sickness behavior, that is reduced activity, hunched posture, and huddling. By the experiment’s termination at 4 hr, 8 of 10 M. musculus treated with LPS had tachypnea, while only one of ten LPS-treated P. leucopus displayed this sign of the sepsis state (p=0.005).

Table 1
Characteristics and treatments of Mus musculus CD-1 and Peromyscus leucopus LL stock.
AnimalGenusSexAge (d)Mass (g)TreatmentTachypneaHct* (%)MCV*WBC*NeutrophilsLymphocytesMonocytesEosinophilsNeutrophils/ lymphocytes
  1. *

    Abbreviations: Hct, hematocrit; MCV, mean cellular volume of erythrocytes; WBC, white blood cell count.

  2. control, saline alone.

Within a given species there was little difference between LPS-treated and control animals in values for erythrocytes. But overall the deermice had lower mean (95% confidence interval) hematocrit at 42 (36-48)%, hemoglobin concentration at 13.8 g/dL (12.1–15.5), and mean corpuscular volume for erythrocytes at 49 fL (47-51) than M. musculus with respective values of 56 (51-62)%, 16.1 g/dL (14.6–17.7), and 60 fL (58-62) (p<0.01). These hematology values for adult CD-1 M. musculus and LL stock P. leucopus in this study were close to what had been reported for these colony populations (CharlesRiver, 2012; Wiedmeyer et al., 2014).

In contrast to red blood cells, the mean numbers of white blood cells in the LPS groups in both species were lower than those of control groups (Figure 1). Controls had a mean 4.9 (3.5–6.4) x 103 white cells per µl among M. musculus and 5.8 (4.2–7.4) x 103 white cells per µl among P. leucopus (p=0.41). For the LPS-treated animals the values were 2.1 (1.5–2.7) x 103 for mice and 3.1 (0.9–5.4) x 103 for deermice (p=0.39). However, there was difference between species among LPS-treated animals in the proportions of neutrophils and lymphocytes in the white cell population. The ratios of neutrophils to lymphocytes were 0.25 (0.14–0.45) and 0.20 (0.13–0.31) for control M. musculus and P. leucopus, respectively (p=0.53). But under the LPS condition. the neutrophil-to-lymphocyte ratio was 0.18 (0.11–0.28) for mice and 0.64 (0.42–0.97) for deermice (p=0.0006). The regression curves for plots of neutrophils and lymphocytes for LPS-treated and control P. leucopus and LPS-treated M. musculus had similar slopes, but the y-intercept was shifted upwards towards a higher ratio of neutrophils to lymphocytes for blood from the LPS group of deermice. Control group mice and deermice and LPS-treated mice had similar percentages (~5%) of monocytes in their blood; the mean monocyte percentage rose to 10% in LPS treated deermice (p=0.12). Eosinophil percentages tended to be higher in deermice at a mean 3.4 (2.1–4.7)% than mice at 1.2 (0.5–1.9)% under either condition (p=0.004).

Total white blood cells, neutrophils, and lymphocytes of Mus musculus (M) and Peromyscus leucopus (P) with or without (control; C) treatment with 10 µg lipopolysaccharide (LPS; L) per g body mass 4 hr previous.

The data are from Table 1. The box plots of left and center panels show values of individual animals and compiled median, quartiles, and extreme values. The linear regressions of the right panel are color-coded according to the species and treatment designations. The outlier value for a M. musculus control (MM17) was excluded from the linear regression for that group.

In the P. leucopus experiment with a tenfold lower dose of LPS and a 12 hr duration, the mean (95% confidence interval) white blood cell count (x 103) at termination 3.5 (2.5–4.5) in controls and 7.9 (6.0–9.7) in the LPS-treated (p=0.01). Even with the higher overall white blood cell count, the increase white cells was proportionately higher for neutrophils than for lymphocytes, as was seen in the deermice in the higher dose LPS experiment. The ratio of neutrophils-to-lymphocytes was 0.20 (0.07–0.32) in the controls and 0.38 (0.26–0.50) in the LPS-treated (p=0.10).

The higher neutrophil to lymphocyte ratio in the deermice exposed to LPS was consistent with the greater neutrophil activation noted by transcriptional analysis (Balderrama-Gutierrez et al., 2021). But many individual genes that constitute this and related gene ontology (GO) terms had transcription levels in the deermice that far exceeded a threefold difference in neutrophil counts. For some genes, the differences were a hundred or more fold, which suggested that the distinctive LPS transcriptional response profile between species was not attributable solely to neutrophil counts.

Genome-wide expression in blood of deermice and mice

We used the respective transcript sets from the reference genomes for P. leucopus and M. musculus for deep coverage RNA-seq with paired-end ~150 nt reads (Figure 2—source data 1 and Figure 2—source data 2). Principle component analyses (PCA) of the P. leucopus data and M. musculus data revealed that untreated controls had coherent profiles within each species (Figure 2). With the exception of one mouse, the LPS-treated M. musculus were also in a tight PCA cluster. In contrast, the LPS-treated deermice displayed a diversity of genome-wide transcription profiles and limited clustering.

Principle component analysis of genome-wide RNA-seq data of Peromyscus leucopus or Mus musculus with or without (blue dot) treatment with LPS 4 hr previous (Figure 2—source data 1 and Figure 2—source data 2).

The individual animals listed in Table 1 are indicated on the graphs. The insets indicate the size and color of the symbol for the experimental condition (LPS-treated or control).

Figure 2—source data 1

Genome-wide RNA-seq data as TPM values for Peromyscus leucopus treated with lipopolysaccharide or saline alone.
Figure 2—source data 2

Genome-wide RNA-seq data as TPM values for Mus musculus treated with lipopolysaccharide or saline alone.

For both species, the number of genes with higher expression with LPS exposure exceeded those with lower or unchanged expression. For P. leucopus and M. musculus, the mean fold-changes were 1.32 (1.29–1.35) and 1.30 (1.24–1.36), respectively (p=0.31). For GO term analysis, the absolute fold-change criterion was ≥2. Because of the ~3 fold greater number of transcripts for the M. musculus reference set than the P. leucopus reference set, application of the same false-discovery rate (FDR) threshold for both datasets would favor the labeling of transcripts as DEGs in P. leucopus. Accordingly, the FDR p values were arbitrarily set at <5 × 10–5 for P. leucopus and <3 × 10–3 for M. musculus to provide approximately the same number of DEGs for P. leucopus (1154 DEGs) and M. musculus (1266 DEGs) for the GO term comparison.

Figure 3 shows the GO terms for the top 20 clusters by ascending p-value for up-regulated and down-regulated in P. leucopus and the corresponding categories for M. musculus. The up-regulated gene profile for P. leucopus featured terms associated with ‘neutrophil degranulation’, ‘myeloid leukocyte activation’, ‘leukocyte migration’, and ‘response to molecule of bacterial origin’. Other sets of up-regulated genes for the deermice were ‘negative regulation of cytokine production’ and ‘regulation of reactive oxygen species metabolic process’. None of these were among the top 20 up-regulated clusters for M. musculus. Indeed, ‘leukocyte activation’ and ‘leukocyte migration’ were GO terms for down-regulated DEGs in M. musculus. Distinctive GO terms for up-regulated genes distinguishing mice from deermice were ‘response to virus’, ‘response to interferon-beta’, ‘response to interferon-gamma’, ‘response to protozoan’, and ‘type II interferon signaling’.

Gene Ontology (GO) term clusters associated with up-regulated genes (upper panels) and down-regulated genes (lower panels) of Peromyscus leucopus (left panels) and Mus musculus (right panels) treated with LPS in comparison with untreated controls of each species (Figure 3—source data 1 and Figure 3—source data 2).

The scale for the x-axes for the panels was determined by the highest -log10 p values in each of the four sets. The horizontal bar color, which ranges from white to dark brown through shades of yellow through orange in between, is a schematic representation of the -log10 p values.

Figure 3—source data 1

Differentially expressed gene analysis for Peromyscus leucopus.
Figure 3—source data 2

Differentially expressed gene analysis for Mus musculus.
Figure 3—source data 3

Comparison of differentially-expressed genes in genome-wide RNA-seq of blood of Peromyscus leucopus and Mus musculus with and without treatment with lipopolysaccharide.

By arbitrary criterion of 100 for the top DEGs by ascending p value for each species, 24 genes were shared between species (Figure 3—source data 3). These included up-regulated Bcl3, Ccl3, Cxcl1, Cxcl2, Cxcl3, Cxcl10, Il1rn, and Sod2. Among the 100 mouse DEGs, 20 were constituents of GO terms ‘response to virus’ or ‘response to interferon-beta’ and only hree were members of GO term sets ‘response to molecule of bacterial origin’ or ‘response to lipopolysaccharide’. In contrast, among the top 100 deermouse DEGs, there were only 2 associated with the virus or type 1 interferon GO terms, but 12 were associated with either or both of the bacterial molecule GO terms.

We confirmed the sex identification for each sample with sex-specific transcripts of Xist for females and Ddx3y for males (Balderrama-Gutierrez et al., 2021). For female and male P. leucopus, there were 5012 transcripts out of 54,466 in the reference set for which there were TPM values of ≥10 in at least one animal in each of the sexes under either condition . The comparison of females to males by fold-changes between LPS-treated and control animals revealed transcripts that were differentially expressed between sexes under LPS treatment (Figure 4 and ). Some were down-regulated in one sex while unchanged in expression in the opposite sex. Of note in this category were different isoforms or variants of Lilra6 (leukocyte immunoglobulin-like receptor, subfamily A, member 6), one of a family of orphan receptors of myeloid cells (Bashirova et al., 2014). The opposite case was exemplified by the Dnajc15 and Hspa8 genes for two chaperones: DnaJ heat shock protein family (Hsp40) member C15 and heat shock protein 8, respectively. These were substantially lower in transcription in the LPS-treated females than in untreated animals, but little changed in LPS-treated males. Coordinates for some other genes, for example Saa5 and Cxcl2, fell outside the prediction limits at the extreme end of up-regulation, but their vectors were within 20–25° of each other. While these and other sex-associated differences merit attention for future studies, overall they were not of sufficient number or magnitude in our view to warrant division by sex for the subsequent analyses, which had the aim of identifying differences applicable for both females and males.

Scatter plot with linear regression of pairs of log2-transformed mean fold-changes between LPS-treated and control P.leucopus by male and female sex (Figure 4—source data 1 and Figure 4—source data 2).

The coefficient of determination (R2), the 95% upper and lower prediction limits for the regression line, and distributions of the values on the x- and y-axes are shown. Selected genes for which their x-y coordinates fall outside the limits of prediction are labeled. Cxcl2, Ibsp, Saa3, Saa5, Sbno2, Serpine1, Slpi, and Steap1 were noted as up-regulated DEGs for the groups with both sexes (Figure 3—source data 3).

Figure 4—source data 1

Differentially expressed gene analysis by genome-wide RNA-seq of 20 female and 20 male P. leucopus treated with lipopolysaccharide or saline.
Figure 4—source data 2

Comparison of female and male P. leucopus for mean fold-changes of LPS-treated to control animals for each of 5012 reference transcripts with a maximum TPM ≥10.

Targeted RNA seq analysis

The emerging picture was of P. leucopus generally responding to LPS exposure as if infected with an extracellular bacterial pathogen, including with activated neutrophils. While M. musculus animals of both sexes shared with P. leucopus some features of an antibacterial response, they also displayed type 1 and type 2 interferon type response profiles associated with infections with viruses and intracellular bacteria and parasites.

Going forward, the challenge for a cross-species RNA-seq was commensurability between annotated transcripts of reference sets. Orthologous genes can be identified, but mRNA isoforms and their 5’ and 3’ untranslated regions may not fully correspond. Accordingly, we limited targeted RNA-seq to protein coding sequences of mRNAs for the corresponding sets of P. leucopus and M. musculus sequences.

The 113 mRNA coding sequences, which are listed in Methods, were drawn from the identified DEGs for P. leucopus and M. musculus from the genome-wide RNA-seq. For cross-species normalization, we first evaluated three methods: (1) normalization using the ratio of mean total reads for all samples to total reads for a given sample, (2) the ratio of reads mapping to a given target transcript (i.e. the numerator) to the reads to transcripts of mitochondrial 12 S rDNA gene (i.e. the denominator), or (3) when the denominator instead was the myeloid cell marker CD45, or protein tyrosine phosphatase, receptor type C, encoded by Ptprc. In humans, mice, and hamsters, Ptprc is expressed by nucleated hematopoietic cells, and the protein CD45 is commonly used as a white cell marker for flow cytometry (Schnizlein-Bick et al., 2002). The coefficients of determination (R2) between comparison pairs (e.g. normalization for total reads vs. normalization by Ptprc reads) within a species were ≥0.95 (Figure 5; Figure 5—source data 1). There was also little difference between the choice of Ptprc or 12 S rRNA transcripts as denominator with respect to cross-species comparisons of LPS-treated to control fold changes. The results indicated that the two normalization methods, one based on a mitochondrion gene and other on a chromosome gene, were commensurate. Given the widespread adoption of CD45 for flow cytometry, we chose Ptprc reads as denominator and as an adjustment for white cell numbers in the samples. Pearson correlation between log-transformed total white blood cell counts and normalized reads for Ptprc across 40 animals representing both species, sexes, and treatments was 0.40 (p=0.01).

Comparison of three different methods for normalization for cross-species targeted RNA-seq.

The normalization options were total reads for the same sample, unique reads for the mitochondrial 12 S rDNA, and unique reads for the Ptprc transcript encoding CD45. The 109 targets and all values for the analysis are in Figure 5—source data 1. For the upper panel, the coefficients of determination (R2) were calculated for each of the pairs and for within each species and across species (columns C-G of Source data 1). The results of this analysis are in the matrix of the upper panel. The lower left panel compares in the same scatterplot the LPS to control fold-changes by either the 12 S or Ptprc normalization method, and the Peromyscus leucopus (P) result regressed on the Mus musculus (M) result for the same gene. The lower right panel of the figure is a scatterplot with linear regression and the R2 value (columns I and J of Source data 1).

Figure 5—source data 1

Comparison of different methods for normalization (total reads, 12S rRNA or Ptprc) for cross-species targeted RNA-seq.

Figure 6 comprises plots of the log-transformed mean ratios for the 10 P. leucopus controls and 10 M. musculus controls and for the 10 P. leucopus and 10 M. musculus treated with LPS (Figure 6—source data 1). For untreated animals (left panel) there was high correlation and a regression coefficient of ~1 between the paired data for deermice and mice. MT-Co1, the gene for mitochondrial cytochrome oxidase 1 gene, and S100a9, which encodes a subunit of calprotectin, were comparably transcribed. But, there were other coding sequences that stood out for either their greater or lesser transcription in untreated deermice than mice. Two examples of greater expression were Arg1 and Mx2, which encodes MX dynaminin-like GTPase 2, while two examples of lesser expression were Mmp8, the gene for matrix metalloprotease 8, and Slpi. There was low to undetectable transcription of Nos2 and Ifng, the gene for interferon-gamma, in the blood of controls of both species.

Figure 6 with 1 supplement see all
Scatter plots with linear regression of pairs of log-transformed (ln) normalized RNA-seq reads for selected coding sequences for control Peromyscus leucopus and Mus musculus (left panel) and LPS-treated P. leucopus and M. musculus (right panel) (Figure 6—source data 1).

The R2 values and selected genes (each with a different symbol) are indicated in each graph. Box plots for a selected 54 of these targets organized by functional characteristics are provided in Figure 6—figure supplement 1.

Figure 6—source data 1

Natural logarithms of ratios of transcript reads of selected genes to Ptprc (Cd45) transcript reads in blood of P. leucopus or M. musculus with or without treatment with LPS by individual animal.

For the LPS-treated animals (right panel Figure 6) there was, as expected for this selected set, higher expression of the majority genes and greater heterogeneity among P. leucopus and M. musculus animals in their responses for represented genes. In contrast to the findings with controls, Ifng and Nos2 had higher transcription in treated mice. In deermice the magnitude of difference in the transcription between controls and LPS-treated was less. A comparatively restrained transcriptional response in deermice was also noted for Mx2. On the other hand, there were greater fold-changes from baseline in P. leucopus than in M. musculus for Mmp8, Slpi, S100a9, and Il1b, the gene for interleukin-1 beta.

Supplementary file 1 lists all the selected targets with the means and confidence intervals for the normalized values for controls and LPS-treated M. musculus and controls and LPS-treated P. leucopus (Source data 1). The fold-changes within each species and between treatments across species are given. The final column is the ratio of the fold-change between LPS to control in P. leucopus to the corresponding value for M. musculus. This along with the derived heat-map of these ratios, presented in the second column, indicates the genes for which there was little difference between species in their responses to LPS—either up or down—as well as those that were comparatively greater or lesser in one species or the other. Several of these genes are considered in other specific contexts below. Of note are the places of Nos2 and Ifng at the bottom of the table, and Il1b near the top at position 20.

‘Alternatively activated’ macrophages and ‘nonclassical’ monocytes in P. leucopus

While we could not type single cells using protein markers, we could assess relative transcription of established indicators of different white cell subpopulations in whole blood. The present study, which incorporated outbred M. musculus instead of an inbred strain, confirmed the previous finding of differences in Nos2, the gene for inducible nitric oxide synthase, and Arg1, the gene for arginase 1, expression between M. musculus and P. leucopus (Figure 5; Supplementary file 1). Results similar to the RNA-seq findings were obtained with specific RT-qPCR assays for Nos2 and Arg1 transcripts for P. musculus and M. musculus (Table 2; Table 2—source data 1).

Table 2
RT-qPCR of blood of LPS-treated and control Peromyscus leucopus and Mus musculus.
Blood mRNA sourceGeneControl mean copies (95% CI)LPS mean copies (95% CI)Fold difference (LPS/control)t test p/Mann-Whitney p
P. leucopusGapdh1.2 (0.40–3.7) x 1052.4 (1.1–5.2) x 1051.950.35/0.49
Nos2191 (141–260)138 (61–315)0.720.47/0.53
Arg14.6 (3.1–6.9) x 10312.3 (3.2–47) x 1032.660.18/0.55
M. musculusGapdh6.1 (2.3–16.0) x 1061.8 (0.80–3.9) x 1060.290.06/0.02
Nos2101 (68–151)1891 (866–4130)18.6<0.00001/0.002
Arg127 (15–20)16 (8–34)0.590.29/0.45
Table 2—source data 1

RT-qPCR of Gapdh, Nos2, and Arg1 transcripts in blood of P. leucopus or M. musculus with or without treatment with LPS.

Low transcription of Nos2 in both in controls and LPS-treated P. leucopus and an increase in Arg1 with LPS was also observed in another experiment for present study where the dose of LPS was 1 µg/g body mass instead of 10 µg/g and the interval between injection and assessment was 12 hr instead of 4 hr (Table 3; Table 3—source data 1).

Table 3
Targeted RNA-seq of Peromyscus leucopus blood in 12 hr experiment with LPS dose of 1 µg/g.
Gene (alternative name)Control (n=3) mean (95% CI)*LPS (n=3) mean (95% CI)*Fold changeFDR p value
Akt1220 (12–4202)514 (321–825)2.30.05
Akt2145 (97–217)336 (236–478)2.30.04
Arg1146 (58–367)2812 (273–28,925)190.018
Cd1482 (12–569)914 (161–5197)110.05
Cd69165 (87–310)68 (14–329)0.420.15
ERV env25 (3–242)40 (7–224)1.60.86
ERV gag-pol3085 (132–14,695)2768 (533–1278)0.90.66
Fcgr340 (25–66)841 (533–1278)210.008
Gapdh7176 (3504–15,142)23811 (5827–97,306)3.30.07
Gbp497 (6–1551)439 (33–5819)4.50.05
Ifit1367 (51–2663)1373 (374–5047)3.70.05
Ifng0 (0–0)0 (0–0)..
Il1b258 (18–3652)1432 (183–11,220)5.60.1
Irf7121 (93–157)11405 (530–245,616)940.003
Isg15429 (184–1001)19505 (11140–34,152)450.005
Mx2157 (73–341)1310 (323–5315)8.30.04
Nos20 (0–0)0 (0–0)..
Oas165 (31–138)1458 (367–5795)220.03
Rigi (Ddx58)38 (3–504)173 (35–845)4.50.07
Saa32 (0–250)6683 (1494–29,896)33720.03
Slpi6 (1-46)779 (326–1864)1230.03
Sod2180 (54–607)3406 (698–16,633)190.03
  1. *

    Mean unique reads for given gene normalized for reads for Ptprc (Cd45) gene for a sample. The 95% confidence intervals (CI) are asymmetric. Actual [gene]/Ptprc ratios are x 10–3 (Source data 1).

  2. FDR, false discovery rate p value.

Table 3—source data 1

Targeted RNA-seq of blood of P. leucopus 12 h after treatment with LPS (1 µg/g) or saline.

In addition to the differences in Nos2 and Arg1 expression for typing macrophage and monocyte subpopulations, there are also the relative expressions of three other pairs of genes: (1) Il12 and Il10, where a lower Il12/Il10 transcription ratio is more characteristic of alternatively activated or M2 type Murray, 2017; van Stijn et al., 2015; (2) Akt1 and Akt2, the genes for two proto-oncogene kinases, where the associations are Akt1 with M2-type and Akt2 with M1-type macrophages Arranz et al., 2012; Vergadi et al., 2017; and (3) CD14 and CD16, or low affinity immunoglobulin gamma Fc region receptor III, encoded by Fcgr3, where low expression of Cd14 and high expression of Fcgr3 is associated with ‘non-classical’ monocytes (Narasimhan et al., 2019). There is evidence that nonclassical monocytes can change to M2-type macrophages (Italiani and Boraschi, 2014).

These four relationships, which are presented as log-transformed transcription ratios for Nos2/Arg1, Il12/Il10, Akt1/Akt2, and Cd14/Fcgr3, are shown in Figure 6. We confirmed the difference between P. leucopus and M. musculus in the ratios of Nos2/Arg1 and Il12/Il10 (3) with outbred mice and normalization for white cells. In both species, the Akt1/Akt2 ratio declined in LPS-treated animals, but for P. leucopus the ratio remained >1.0 even among LPS-treated animals, while in the blood of M. musculus the ratio was <1.0 at baseline and declined further in the LPS-treated animals.

An orthologous gene for Ly6C (Bothwell et al., 1988), a protein used for typing mouse monocytes and other white cells, has not been identified in Peromyscus or other Cricetidae family members. Therefore, expression of Cd14 was compared with expression of the Ly6c alternative Fcgr3, which deermice and other cricetines do have. In mice, the Cd14/Fcgr3 transcription ratio increased from baseline in the LPS group. In the deermice, the ratio in control animals was midway between the two groups of mice but there was a marked decrease in the LPS-treated deermice (Figure 7). This was not associated with a fall in the absolute numbers or percentages of monocytes in the blood of these animals (Table 1).

Box plots of natural log (ln)-transformed ratios of four pairs of gene transcripts from targeted RNA-seq analysis of blood of Peromyscus leucopus (P) or Mus musculus (M) with (L) or without (C) treatment with LPS.

The values are from Source data 1. Upper left, Nos2/Arg1; upper right, Il12/Il10; lower left, Akt1/Akt2; lower right, Cd14/Fcgr3.

Taken together, the Nos2/Arg1, Il12/Il10, Akt1/Akt2, and Cd14/Fcgr3 relationships document a disposition toward alternatively activated macrophages and nonclassical monocytes in P. leucopus both before and after exposure to LPS. This contrasts with profiles consistent with a predominance of classically activated macrophages and classical monocytes in mice.

Interferon-gamma and interleukin-1 beta dichotomy between deermice and murids

For mice the Ifng transcript was one of the top ranked DEGs by both fold-change and adjusted p value by genome-wide RNA-seq (Supplementary file 1). In contrast, for P. leucopus Ifng was far down the list, and the comparably ranked DEG instead was Il1b. This inversion of relationships between two pro-inflammatory cytokines was confirmed by analysis of the individual animals of both species (Figure 8). There was little or no detectable transcription of Ifng in the blood of deermice in which Il1b expression was high. There was also scant to no transcription of Ifng in the blood of P. leucopus 12 hr after injection of LPS (Table 3).

Transcripts of genes for interferon-gamma and interleukin-1 beta by targeted RNA-seq of the blood of Peromyscus leucopus (P) or Mus musculus (M) with (L) or without (C) treatment with LPS.

The top panels are box plots of the individual values. The lower left panel is a scatter plot of Il1b on Ifng transcription values. The lower right panel is a Discriminant Analysis of these pairs of values where Factor 1 corresponds to Ifng, and Factor 2 corresponds to Il1b. Values for analysis are from Source data 1.

The up-regulation of the interferon-gamma gene within 4 hr of exposure to LPS was not limited to the species M. musculus. In an experiment with the rat R. norvegicus, we used two different LPS doses (5 µg/g and 20 µg/g), but the same 4 hr endpoint and whole blood as the sample. Both groups of LPS-treated rats had lowered total white blood cells and, like the mice, lower neutrophil-to-lymphocyte ratios compared to controls (Table 4; Table 4—source data 1). There were also elevations of interferon-gamma, interleukin-6, and interleukin-10 proteins from undetectable levels in the blood of the treated rats. The values for rats receiving 5 µg/g or 20 µg/g doses were similar, so these groups were combined. By targeted RNA-seq, there were 24 x fold-changes between the LPS-treated rats and control rats for Ifng and Nos2 but only ~3 x fold-change for Il1b (Table 4).

Table 4
Hematology, cytokines, and targeted RNA-seq of LPS-treated and control Rattus norvegicus.
VariableControl (n=5) mean (95% CI)*LPS (n=11) mean (95% CI)*,Fold changeFDR p value
Hematocrit (%)48 (46–50)48 (46–49)1.01E+00
White blood cells7660 (7200–8310)4980 (2020–7940)0.752E-01
Neutrophils3680 (3260–4090)1410 (520–2290)0.384E-03
Lymphocytes3170 (3010–3330)2830 (1230–4430)0.898E-01
Neutrophil/lymphocyte1.17 (1.01–1.33)0.49 (0.44–0.55)0.427E-09
Blood cytokines (pg/ml)
Interleukin-60 (0–0)36933 (21676–52190).5E-15
Interleukin-109 (1-17)640 (477–802)712E-09
Interferon-gamma0 (0–0)9091 (7126–11056).9E-20
Targeted RNA-seq
Akt135.8 (29.8–42.9)24.3 (21.5–27.5)0.684E-03
Akt250.8 (44.9–57.4)109 (95.2–125)2.29E-06
Arg10.04 (0.02–0.08)0.21 (0.10–0.44)4.82E-02
Cd147.7 (5.3–11.2)43.4 (29.6–63.6)5.69E-05
Cd1770.89 (0.43–1.8)190 (143–251)2132E-10
Cd332.3 (27.7–37.6)21.9 (18.5–25.8)0.681E-02
Cd6917.9 (16.7–19.2)58.9 (49.1–70.7)3.39E-07
Cgas1.5 (1.3–1.6)12.8 (10.8–15.1)8.73E-10
Cxcl100.43 (0.34–0.56)130 (93.7–181)3021E-11
Dhx587.1 (6.7–7.6)113 (97.3–130)15.83E-12
ERV env8.4 (7.5–9.3)713 (624–815)85.31E-14
ERV gag-pol6.0 (5.4–6.7)506 (449–570)84.37E-15
Fcgr2a114 (87.0–150)764 (631–925)6.74E-08
Fcgr2b32.5 (24.6–43.1)161 (127–204)4.92E-06
Fcgr315.2 (13.6–17.0)13.9 (11.8–16.3)0.915E-01
Gapdh327 (237–451)1643 (1385–1949)5.02E-07
Gbp435.7 (33.6–38.0)269 (237–306)7.53E-11
Ifih118.7 (17.1–20.4)165 (149–184)8.82E-12
Ifit1102 (70.0–147)756 (677–844)7.43E-09
Ifng0.47 (0.32–0.67)10.3 (6.4–16.5)22.11E-06
Il100.12 (0.07–0.21)4.5 (3.4–5.8)38.25E-09
Il120.07 (0.04–0.11)3.2 (2.0–4.9)45.97E-08
Il1b58.6 (39.7–86.4)618 (503–760)10.62E-08
Il60.06 (0.05–0.08)4.4 (2.9–6.6)70.96E-09
Irf744.8 (36.9–54.3)443 (372–528)9.96E-10
Isg1515.6 (13.1–18.7)624 (534–729)39.96E-13
Itgam66.3 (52.5–83.7)208 (161–269)3.19E-05
Mmp875.2 (50.4–112)519 (438–615)6.97E-08
Mx240.7 (35.9–46.2)900 (780–1039)22.11E-12
Nos232.4 (17–60.6)2990 (2491–3589)92.41E-10
Oas123.1 (18.8–28.4)151 (140–164)6.63E-11
Rigi (Ddx58)8.6 (7.8–9.4)151 (135–168)17.61E-13
S100a9298 (190–466)2884 (2269–3666)9.72E-07
Saa10.60 (0.49–0.73)699 (552–884)11674E-14
Slpi20.2 (13.1–31.3)262 (197–347)12.91E-07
Sod263.8 (51.1–79.6)901 (759–1070)14.12E-10
Tlr45.3 (4.6–6.0)20.1 (17.2–23.6)3.88E-08
Tnf1.1 (0.63–1.9)78.8 (62.6–99.1)72.82E-10
Akt1/Akt20.70 (0.65–0.76)0.22 (0.19–0.25)0.312E-08
Cd14/Fcgr30.51 (0.34–0.76)3.14 (2.26–4.36)6.161E-05
IL12/IL100.54 (0.22–1.37)0.70 (0.51–0.95)1.305E-01
Nos2/Arg1741 (403–1362)14244 (7615–26646)19.25E-05
  1. *

    For targeted RNA-seq it is mean unique reads for given gene normalized for reads for Ptprc (Cd45) gene for a sample. The 95% confidence intervals (CI) are asymmetric. Actual [gene]/Ptprc ratios are x 10–3.

  2. The results for rats receiving 5 µg/g (n=6) and 20 µg/g (n=5) were combined.

Table 4—source data 1

Targeted RNA-seq of blood of Rattus norvegicus with or without treatment with LPS and with normalization by Ptprc transcripts.
Table 4—source data 2

Differentially expressed genes of genome-wide RNA-seq of blood of R. norvegicus with and without treatment with LPS.

Given these findings, we asked why the interferon-gamma response observed in CD-1 mice and rats here was not as pronounced in BALB/c mice (Balderrama-Gutierrez et al., 2021). Accordingly, we used the RNA-seq reads obtained from the prior study in combination with the reads of the present study and carried out targeted RNA-seq (Figure 9). The BALB/c inbred mice had, like the CD-1 mice, modest elevations of Il1b transcription. Ifng expression was also elevated in the BALB/c animals but not to the degree noted in CD-1 mice or rats. One explanation is an inherent difference of BALB/c mice from other strains in their lower interferon-gamma response to LPS (Kuroda et al., 2002; Soudi et al., 2013).

Scatter plots of log-transformed normalized transcripts of genes for interleukin-1 beta (Il1b; left panel) or nitric oxide synthase 2 (Nos2; right panel) on interferon-gamma (Ifng) of blood of Peromyscus leucopus (Pleu) or Mus musculus (outbred CD-1 and inbred BALB/c) with (LPS) or without (con) treatment with lipopolysaccharide 4 hr previously.

The data are from the present study (Pleu 2 and CD-1) (Source data 1) and from the study of Balderrama-Gutierrez et al., 2021 (Pleu 1 and BALB/c) (Figure 9—source data 1).

Figure 9—source data 1

Targeted RNA-seq of blood with normalization by Ptprc of LPS-treated and control P. leucopus and BALB/c M. musculus reported in Balderrama-Gutierrez et al.

Interferon-gamma and inducible nitric oxide synthase

Interferon-gamma is a determinant of Nos2 expression (Lowenstein et al., 1993; Salkowski et al., 1997). So, the scant transcription of Ifng in P. leucopus conceivably accounted for the low expression of Nos2 in that species. The analysis shown in upper left panel of Figure 10 shows a tight correlation between the levels of transcription of Ifng and Nos2 for both species and both experimental conditions (Figure 10—figure supplement 1). A significant correlation was also observed for the combined set of animals between the ratios of Nos2 to Arg1 on Ifng to Il1b (upper right panel), an indication of co-variation between Ifng expression and macrophage polarization.

Figure 10 with 1 supplement see all
Normalized transcripts of Nos2, Ifng, and Cd69 in targeted RNA-seq analysis of blood of Peromyscus leucopus (P) or Mus musculus (M) with (L) or without (C) treatment with LPS.

Upper left: scatter plot of individual values for Nos2 on Ifng with linear regression curve and coefficient of determination (R2). Upper right: linear regression with R2 of natural logarithms (ln) of Nos2/Arg1 on Ifng/Il1b. Lower left: Box plots of individual values of normalized transcripts of Cd69. Lower right: Scatter plot of Ifng on Cd69 transcription with separate regression curves and R2 values for M. musculus and P. leucopus. Values for analysis are in Source data 1. Box plots for Nos2 and Arg1 are provided in Figure 10—figure supplement 1, and box plots for Ifng and Il1b are provided in Figure 8.

The plausible sources of interferon-gamma mRNA in whole blood are T-cells, Natural Killer cells, and Type 1 Innate Lymphoid Cells Quatrini et al., 2017. A DEG for M. musculus by both genome-wide and targeted RNA-seq (Supplementary file 1) was Cd69, which encodes a C-type lectin protein and an early activation antigen for these cells Heinzelmann et al., 2000. In P. leucopus, transcription of Cd69 occurred in the blood of control P. leucopus, but it was the same or only marginally different for the LPS-treated animals (lower left panel). In contrast, in M. musculus the baseline transcription of Cd69 was below that of P. leucopus, while in the LPS-treated mice it was many fold higher. In mice, transcripts for Cd69 correlated tightly with Ifng transcription, but in the deermice there was little correlation between Cd69 and Ifng expression at those low levels (lower right panel).

The findings are consistent with CD69-positive cells being a source of Ifng in mice. Cd69 transcription was comparatively higher in control deermice than in control mice, so we presume that deermice have CD69-positive cells at baseline. One explanation then for the comparatively few Ifng transcripts in the deermice after LPS is a diminished responsiveness of these cells. Tlr4 expression increased ~threefold more in P. leucopus than in M. musculus after LPS (Supplementary file 1 ), but the magnitude of the decline in expression of Cd14 in deermice than mice was even greater. CD14 is required for LPS-stimulated signaling through surface TLR4 Mazgaeen and Gurung, 2020, and, as such, its decreased availability for this signaling pathway is a possible explanation for the moderated response to LPS in P. leucopus.

Interferon-stimulated genes and RIG-I-like receptors

As noted, GO terms differentiating mice from deermice included ‘response to interferon-beta’ and ‘response to virus’ (Figure 3). There was also the example of Mx2’s product, an ISG with antiviral activity on its own, that showed a greater fold-change from baseline in mice than in deermice (Figure 5). Five other ISGs (and encoding genes)—guanylate binding protein 4 (Gbp4), interferon-induced protein with tetratricopeptide repeat (Ifit1), interferon regulatory factor 7 (Irf7), ubiquitin-type modifier ISG15 (Isg15), and 2’–5’ oligoadenylate synthase 1 A (Oas1a)—had higher transcription in all the LPS-treated animals. But the magnitude of fold change was less in the deermice, ranging from 6–25% of what it was in the LPS group of mice (Supplementary file 1).

The up-regulation of these ISGs was evidence of an interferon effect, but transcripts for interferon-1 beta (Ifnb) or -alpha (Ifna) themselves were scarcely detectable in deermice or mice in the blood under either condition. We then considered pattern recognition receptors (PRR) that might be part of a signaling pathway leading to ISG expression. Among the DEGs from the genome-wide analyses were genes for four cytoplasmic PRRs: (1) Rigi (formerly called Ddx58), which encodes the RNA helicase retinoic acid-inducible I (RIG-I); (2) Ifih1, which encodes interferon induced with helicase C domain 1, also known as MDA5 and a RIG-I-like receptor; (3) Dhx58, which encodes LGP2, another RIG-I-like receptor; and (4) Cgas, which encodes cyclic GMP-AMP synthase, part of the cGAS-STING sensing pathway.

All four cytoplasmic PRRs were upregulated in the blood of LPS-treated mice and deermice (Supplementary file 1). But, again, for each of them the magnitude of fold change was less by 50–90% in treated P. leucopus than in M. musculus. The coefficients of determination for the six ISGs and the four PRRs are provided in Figure 11. For most of the pairs there was evidence of covariation across all 40 animals. When the correlation was low across all the data, for example between the ISG gene Mx2 and the PRR gene Rigi or ISG genes Mx2 and Gbp4, it was high within a species.

Figure 11 with 1 supplement see all
Co-variation between transcripts for selected PRRs and ISGs in the blood of Peromyscus leucopus (P) or Mus musculus (M) with (L) or without (C) LPS treatment.

Top panel: matrix of coefficients of determination (R2) for combined P. leucopus and M. musculus data. PRRs are indicated by yellow fill and ISGs by blue fill on horizontal and vertical axes. Shades of green of the matrix cells correspond to R2 values, where cells with values less than 0.30 have white fill and those of 0.90–1.00 have deepest green fill. Bottom panels: scatter plots of log-transformed normalized Mx2 transcripts on Rigi (left), Ifih1 (center), and Gbp4 (right). The linear regression curves are for each species. For the right-lower graph the result from the General Linear Model (GLM) estimate is also given. Values for analysis are in Source data 1; box plots for Gbp4, Irf7, Isg15, Mx2, and Oas1 are provided in Figure 11—figure supplement 1.

These findings were evidence that pathways in P. leucopus for PRR signaling and ISG expression functioned similarly to those in M. musculus but differed under these experimental conditions in magnitude of the changes, being more moderate in the deermice.

Endogenous retroviruses in deermice, mice, and rats after LPS exposure

The six ISGs are nonexclusive consequences of activity of type 1 interferons. What we could document was the association of transcription of the genes for the cytoplasmic PPRs, including RIG-I, and the ISGs in both species, as well as the distinction between deermice in the magnitude of the responses of both PRRs and ISGs. These findings led us to ask could be a pathogen-associated molecular pattern (PAMP) for signaling pathways leading to expression of type 1 interferons.

One of these is endogenous retroviruses (ERV). The activity of these diverse, abundant, and pervasive elements have been recognized as one of the drivers of innate immune responses to a microbe (Hurst and Magiorkinis, 2015; Lima-Junior et al., 2021; Rangel et al., 2022). Our attention was drawn to ERVs by finding in the genome-wide RNA-seq of LPS-treated and control rats. Two of the three highest scoring DEGs by FDR p value and fold-change criteria were a gag-pol transcript (GenBank accession XM_039101019.1) for an ERV polyprotein and an env transcript (XM_039113367) for an envelope (Env) protein that is similar to that of murine leukemia viruses (MLV) (Table 4; Table 4—source data 2).

We returned to the mouse and deermouse data. There were four MLV-type or other ERV env transcripts among the 1266 genome-wide RNA-seq DEGs for M. musculus. But, there was no transcripts for an ERV Env protein annotated as such among the 1154 DEGs identified for P. leucopus (Figure 3—source data 3). One possible explanation for the difference was an incomplete annotation of the P. leucopus genome. We took three approaches to rectify this. The first was to examine the DEGs for P. leucopus that encoded a polypeptide ≥200 amino acids and was annotated for the genome as ‘uncharacterized’. A search of both the virus and rodent proteins databases with these candidates identified two that were homologous with gag and pol genes of mammalian ERVs.

For a second approach, we carried out a de novo transcript assembly of mRNA reads from blood of LPS-treated and control P. leucopus and used the resultant contigs as the reference set for RNA-seq analysis. This identified two contigs that were measurably transcribed in the blood, differentially expressed between conditions, and homologous to ERV sequences. One would encode an Env protein that was identical to a P. leucopus coding sequence (XM_037209467) for a protein annotated as ‘MLV-related proviral Env protein’. The second was a gag-pol sequence that was near-identical to a gag-pol transcript (XM_037208848) identified by the first approach.

The third approach was to scan the P. leucopus genome for nonredundant sequences, defined as <95% identity, that were homologous with ERV gag-pol sequences, which are not typically annotated because of masking for repetitive sequences. This analysis yielded 615 unique sequences. These were used in turn as a reference set for RNA-seq. There were four sequences that met the criterion of FDR -value <0.01. Three were transcribed at 5- to 40-fold higher levels in LPS-treated deermice than in controls. But all three, as well as the fourth, a down-regulated DEG, were ERV relics with truncations, frame shifts, and in-frame stop codons. These were assessed as non-coding RNAs and not further pursued in this study.

To represent P. leucopus in a targeted RNA-seq comparison with mice and rats, we settled on the above-referenced env and gag-pol coding sequences in blood mRNA. Representing M. musculus were ERV env transcript XM_036160206 and gag-pol transcript XM_036154935. For rats, we chose env and gag-pol transcripts that were second and third ranked DEGs in the genome-wide RNA-seq as noted above. Because of length differences for the coding sequences, the unit used for cross-species analysis was reads per kilobase before normalization for Ptprc transcription.

The left panel of Figure 12 shows the striking transcriptional fold-change in LPS-treated rats of these env and gag-pol transcripts over controls. Of lesser magnitude but no less significant was the fold-change observed M. musculus for both env and gag-pol sequences. In both mice and rats, env and gag-pol read values were highly correlated across conditions. In contrast, in P. leucopus the magnitudes of fold-change upwards for gag-pol was less than in mice or rats, and transcription of the env sequence was actually lower in LPS-treated animals than in controls. While there was a tight association between env and Rigi transcription in the M. musculus, this was not observed in P. leucopus. Rigi transcription was moderately higher at the time that the env’s transcription was lower in the LPS group.

Figure 12 with 1 supplement see all
Scatter plots of endogenous retrovirus (ERV) env and gag-pol transcripts (left) and association of ERV env with Rigi transcription (right) in the blood of Peromyscus leucopus (Pero.; P), M musculus (Mus; M), or R. norvegicus (Rattus) with (L) or without (control; C) treatment with LPS.

In right panel, the linear regression curve and coefficients of determination (R2) for P. leucopus and M. musculus are shown. Values for analysis are in Source data 1; box plots for ERV env and ERV gag-pol transcripts are provided in Figure 12—figure supplement 1.

Borrelia hermsii infection of P. leucopus

The phenomena reported so far were consequences of exposures to a particular PAMP—bacterial lipopolysaccharide with its hallmark lipid A moiety--recognized by a particular PRR, TLR4. While the focus was primarily on events downstream from that initial signaling, we asked in a concluding study whether the profile observed in P. leucopus applied in circumstances when the PAMP or PAMPs did not include LPS. This question is germane, given P. leucopus’ role as a natural host for B. burgdorferi. This organism and other members of the spirochete family Borreliaceae do not have LPS (Barbour, 2018; Takayama et al., 1987), but they have abundant lipoproteins, which are agonists for TLR2 in a heterodimer with TLR1 (Salazar et al., 2009). B. burgdorferi is transiently blood-borne at low densities in P. leucopus, but in its life cycle B. burgdorferi is mainly tissue-associated in vertebrate hosts (Barbour et al., 2009). We previously observed that the blood of B. burgdorferi-infected P. leucopus manifested few DEGs in comparison to skin (Long et al., 2019). More comparable to the LPS experimental model is infection of P. leucopus with a relapsing fever Borrelia species, which commonly achieve high densities in the blood. P. leucopus is a reservoir for Borrelia miyamotoi, which causes hard tick-borne relapsing fever (Barbour et al., 2009), and the related P. maniculatus is a natural host for the soft tick-borne relapsing fever agent B. hermsii (Johnson et al., 2016).

Accordingly, we used blood RNA-seq reads, which were taken from a prior study of B. hermsii infection of P. leucopus (Balderrama-Gutierrez et al., 2021), for targeted analysis with the same reference set employed for the LPS analyses (Table 5; Table 5—source data 1). The blood samples were taken from infected and uninfected animals on day 5, when bacteremia was at its peak, as documented by microscopy of the blood, qPCR of the spleen, and transcripts of a B. hermsii plasmid in the RNA extracts of the blood. As expected for B. hermsii infection (Crowder et al., 2016), the spleen was enlarged in infected animals.

Table 5
Targeted RNA-seq of Peromyscus leucopus with and without Borrelia hermsii infection.
VariableUninfected (n=3) mean (95% CI)*Infected (n=4) mean (95% CI)*Fold changeFDR p value
B. hermsii qPCR of spleen.13615 (1882–98,476)..
B. hermsii reads blood.3487 (743–16,362)..
% spleen/body mass0.15 (0.12–0.19)0.36 (0.26–0.51)2.41E-02
Targeted RNA-seq
Akt1184 (135–253)347 (191–630)1.883E-01
Akt292.9 (72.4–119)141 (89.4–222)1.523E-01
Arg1247 (96.9–630)1375 (848–2230)5.574E-02
Cd14308 (119–799)598 (357–1002)1.943E-01
Cd1772.11 (0.71–6.27)35.9 (11.9–108)17.04E-02
Cd69133 (114–155)65 (33.6–128)0.492E-02
Cxcl100.33 (0.14–0.76)4.85 (2.74–8.59)14.72E-02
ERV env26.8 (22.4–32.1)29.2 (14.8–57.8)1.099E-01
ERV gag-pol1853 (1351–2542)1578 (820–3037)0.858E-01
Fcgr2a44.8 (24.0–83.6)715 (303–1689)16.02E-02
Fcgr2b47.3 (30.2–74.3)578 (167–2000)12.25E-02
Fcgr330.6 (18.6–50.4)392 (171–897)12.82E-02
Gapdh1985 (1142–3447)5366 (2383–12,081)2.702E-01
Gbp4126 (82.3–193)289 (130–644)2.303E-01
Ifit1223 (107–465)604 (303–1203)2.712E-01
Ifng0.58 (0.09–3.92)2.28 (0.86–6.06)3.943E-01
Il100.25 (0.07–0.87)1.49 (0.31–7.28)5.943E-01
Il120.43 (0.23–0.81)1.13 (0.45–2.88)2.633E-01
Il1b477 (174–1308)2828 (1325–6034)5.937E-02
Irf793.3 (13.4–65)626 (196–1998)6.712E-01
Isg15302 (30.1–3030)1922 (623–5934)6.363E-01
Itgam72.2 (44.5–117)322 (211–492)4.452E-02
Mmp87.1 (2.74–18.6)537 (148–1952)75.22E-02
Mx2152 (48.6–476)167 (48.0–582)1.109E-01
Nos20.16 (0.08–0.30)0.32 (0.13–0.80)2.014E-01
Oas151.3 (6.75–390)159 (39.2–643)3.105E-01
Rigi (Ddx58)38.7 (18.9–79.2)55.7 (33.9–91.5)1.445E-01
S100a91739 (657–4596)18430 (6546–51,883)10.65E-02
Saa30.49 (0.13–1.87)212 (25.9–1733)4312E-02
Slpi0.41 (0.18–0.95)166 (49.0–566)4011E-02
Sod2104 (51.4–211)2011 (804–5028)19.32E-02
Tlr283.2 (59.7–116)371 (234–587)4.462E-02
Tlr444.8 (26.1–77.0)256 (138–474)5.713E-02
Akt1/Akt22.0 (1.7–2.3)2.5 (2.1–2.9)1.251E-01
Cd14/Fcgr311.3 (4.8–17.9)1.7 (0.72–2.8)0.152E-02
IL12/IL102.3 (0.00–5.0)2.8 (0.0–7.6)1.219E-01
Nos2/Arg10.001 (0.0–0.002)0.0001 (0.0–0.0004)0.282E-01
  1. *

    For targeted RNA-seq it is mean unique reads for given gene normalized for reads for Ptprc (Cd45) gene for a sample. The 95% confidence intervals (CI) are asymmetric. Actual [gene]/Ptprc ratios are x 10–3.

  2. † Normalized PE150 reads mapping to cp6.5 plasmid of B. hermsii.

Table 5—source data 1

Targeted RNA-seq of blood with normalization by Ptprc of P. leucopus with and without infection by Borrelia hermsii.

Similarities in the profiles for the LPS-treated and B. hermsii-infected deermice were as follows: (1) low levels of transcription of Nos2 and Ifng that contrasted with the high levels for Arg1 and Il1b expression in the same animals, (2) maintenance of the Akt1/Akt2 ratio >1.0 under both conditions, (3) reduction of the Cd14/Fcgr3 ratio, (4) decreased transcription of Cd69, and (5) stable, low transcription of ERV env and gag-pol loci with only marginal increases in transcription of ISGs and RIG-I-like receptors. Other equivalences under the two experimental conditions included increases in expression of genes for superoxide dismutase 2, low-affinity Fc gamma receptors, and secretory leukocyte peptidase inhibitor. Thus, the responses that distinguish deermice are not confined to the singular case of LPS as the elicitor.


Study limitations

The approach was forward and unbiased, looking for differences between species broadly across their transcriptomes. The findings lead to hypotheses, but reverse genetics in service of that testing was not applied here. In selective cases we could point to supporting evidence in the literature on M. musculus and the phenotypes of relevant gene knockouts, but there are no such resources for Peromyscus as yet. The resource constraint also applies to the availability of antibodies for use with Peromyscus for immunoassays for specific proteins, for example interferon-gamma, in serum, or for cell markers, for example CD69, for flow cytometry of white blood cells.

While a strength of the study was use of an outbred population of M. musculus to approximate the genetic diversity of the P. leucopus in the study, this meant that some genes of potential relevance might have gone undetected, that is from type II error. The variances for a sample of genetically diverse outbred animals, like the LL stock of P. leucopus (Long et al., 2019; Long et al., 2022), would be expected to be greater than for the same sized sample of inbred animals. For some traits, especially ones that are complex or under balancing selection, even sample sizes of 10 in each group may not have provided sufficient power for discrimination between deermice and mice. For the same reason differences between sexes of a species in their responses might have been undetected. The interpretations applied to mixed-sex groups of deermice and mice. Expression strongly associated with female or male sex could have yielded an average fold change for the whole group that fell below the screen’s threshold.

The parameters for the experiment of LPS dose, the route, and duration of experiment each might have had different values under another design. Those particular choices were based on past studies of deermice and mice (Balderrama-Gutierrez et al., 2021; Langeroudi et al., 2014). In another experiment, we found that with doses twice or half those given the deermice the responses by rats to the different doses were indistinguishable by hematology, cytokine assays, and RNA-seq. Thus, there seems to be some latitude in the dose and still achieving replication. We obtained similar results for P. leucopus when we looked at a replicate of the experiment with the same conditions (Balderrama-Gutierrez et al., 2021), or when the dose was lower and duration lengthened to 12 hr (this study). The analysis here of the B. hermsii infection experiment also indicated that the phenomenon observed in P. leucopus was not limited to a TLR4 agonist.

While the rodents in these experiments were housed in the same facility and ate the same diet, we cannot exclude inherent differences in gastrointestinal microbiota between species and individual outbred animals as co-variables for the experimental outcomes. We reported differences between the LL stock P. leucopus and BALB/c M. musculus of the same age and diet in their microbiomes by metagenomic analysis and microbiologic means (Milovic et al., 2020). This included a commensal Tritrichomonas sp. in P. leucopus but not in the M. musculus in the study. The presence of these protozoa affects innate and adaptive immune responses in the gastrointestinal tract (Chiaranunt et al., 2022; Escalante et al., 2016), but it is not clear whether there are systemic consequences of colonization by this flagellate.

LPS, ERVs, and interferons

The results confirm previous reports of heightened transcription of ERV sequences in mice or mouse cells after exposure to LPS (Hara et al., 1981; Jongstra and Moroni, 1981; Stoye and Moroni, 1983). Here we add the example of the rat. The LPS was administered in solution and not by means of membrane vesicles. The sensing PRR presumably was surface-displayed, membrane-anchored TLR4 (Mazgaeen and Gurung, 2020). It follows that a second, indirect of LPS on the mouse is through its provocation of increased ERV transcription intracellularly. ERV-origin RNA, cDNA and/or protein would then be recognized by a cytoplasmic PRR. RIG-I was one associated with ERV transcription in this study. Kong et al. reported that LPS stimulated expression of Rigi in a mouse macrophages but did not investigate ERVs for an intermediary function in this phenomenon (Kong et al., 2009). As was demonstrated for LINE type retrotransposons in human fibroblasts, intracellular PRR signaling can trigger a type 1 interferon response (De Cecco et al., 2019). The combination of these two signaling events, that is one through surface TLR4 by LPS itself and another through intracellular PPR(s) by to-be-defined ERV products, manifested in mice and rats as a response profile that had features of both a response to a virus with type 1 interferon and ISGs and a response to a bacterial PAMP like LPS with acute phase reactants such as calprotectin and serum amyloid.

This or a similar phenomenon has been observed under other circumstances. In humans, there was heightened transcription of retrotransposons in patients with septic shock (Mommert et al., 2020), as well as in peripheral blood mononuclear cells from human subjects experimentally injected with LPS (Pisano et al., 2020). Bacteria like Staphylococcus epidermidis that express TLR2 agonists, such as lipoteichoic acid, promoted expression of ERVs, which in turn modulated host immune responses (Lima-Junior et al., 2021). A synthetic analog of a B. burgdorferi lipoprotein activated human monocytic cells and promoted replication of the latent HIV virus in cells that were persistently infected (Norgard et al., 1996).

P. leucopus does not fit well with this model. Instead of the prominent interferon-gamma response observed in mice and rats, there were prominent responses of interleukin-1 beta and genes associated with neutrophil activation. Instead of the much heightened expression of ISGs, like Mx2 and Isg15, in mice treated with LPS, the deermice under the same condition had a more subdued ISG transcription profile. Instead of increased expression of ERV Env protein sequences in blood of mice and rats treated with LPS, there was decreased transcription of the homologous ERV env in like-treated P. leucopus.

This suppression in the deermice may be attributable to defensive adaptations of Peromyscus to repeated invasions of endogenous retroviruses, as Gozashti et al. has proposed for P. maniculatus (Gozashti et al., 2023). This includes expanding the repertoire of silencing mechanisms, such as Kruppel-associated box (KRAB) domain-containing zinc finger proteins (Yang et al., 2017). Like P. maniculatus, P. leucopus has an abundance of Long Terminal Repeat retrotransposons, several named for their endogenous retrovirus heritages (Long et al., 2019). Our initial analysis of the P. leucopus genome reported a depletion of KRAB domains compared to Muridae (Long et al., 2019). But a subsequent annotation round identified several genes for KRAB domain zinc finger proteins in P. leucopus, including Zfp809 (XP_006982432), which initiates ERV silencing (Wolf et al., 2015), and Zfp997 (XP_037067826), which suppresses ERV expression (Treger et al., 2019). Another possible adaptation in P. leucopus is the higher baseline expression of some ISGs as noted here (Figure 11; Figure 11—figure supplement 1).

Reducing differences between P. leucopus and murids M. musculus and R. norvegicus to a single attribute, such as the inactivation of Fcgr1 in P. leucopus (Barbour et al., 2023), may be fruitless. But the feature that may best distinguish the deermouse from the mouse and rat is its predominantly anti-inflammatory quality. This characteristic likely has a complex, polygenic basis, with environmental (including microbiota) and epigenetic influences. An individual’s placement is on a spectrum or, more likely, a landscape rather than in one or another binary or Mendelian category.

One argument against a purely anti-inflammatory characterization is the greater neutrophil numbers and activity in P. leucopus compared to M. musculus in the LPS experiment. The neutrophil activation, migration, and phagocytosis would be appropriate early defenses against a pyogenic pathogen. But if not contained, they bring local and systemic risks for the host. This damage would not likely be from nitric oxide and reactive nitrogen species, given the minimal Nos2 transcription. But deermice showed heightened expression of genes for proteases, such as Mmp8, enzymes for reactive oxygen species, such as NADPH oxidase 1 (Nox1), and facilitators of neutrophil extracellular traps, such as PAD4 (Padi4) (Supplementary file 1 ). We had previously identified possible mitigators, such as secretory leuckocyte peptidase inhibitor and superoxide dismutase 2 (Balderrama-Gutierrez et al., 2021). These findings were replicated here. The topic of neutrophil activation and these and other possible counters is considered in more detail elsewhere.

An anti-inflammatory disposition but at what cost?

An assignment of infection tolerance to a host and pathogen pairing assumes sufficient immunity against the microbe to keep it in check if elimination fails. P. leucopus and P. maniculatus, are in this sense ‘immunocompetent’ with respect to the microbes they host and with which they may share a long history (Hoen et al., 2009). Yet, has this balance of resistance and tolerance for certain host-associated microbes been achieved in a trade-off that entails vulnerabilities to other types of agents?

The selection of LPS as the experimental model was meant to cover this contingency, at least for the common denominator of acute inflammation many types of infections elicit. But LPS studies revealed potential weaknesses that some pathogens might exploit. One of these is the low expression of inducible nitric oxide. Although Nos2 gene knockouts in M. musculus had lower LPS-induced mortality than their wild-type counterparts, the mutants were more susceptible to the protozoan Leishmania major and the facultative intracellular bacterium Listeria monocytogenes (MacMicking et al., 1995; Wei et al., 1995). While there are no known studies of either of these pathogens in P. leucopus, the related species P. yucatanicus is the main reservoir for Leishmania mexicana in Mexico (Chable-Santos et al., 1995). Compared with M. musculus, which suffer a high fatality rate from experimental infections with L. mexicana, P. yucatanicus infections are commonly asymptomatic (Loría-Cervera et al., 2018).

Given the restrained interferon and ISG response shown by P. leucopus, another plausible vulnerability would be viral infections. But other studies suggest that neither RNA nor DNA viruses pose an inordinately high risk for Peromyscus. Both tolerance of and resistance to the tickborne encephalitis flavivirus Powassan virus by P. leucopus were demonstrated in an experimental model in which mice, by contrast, were severely affected Mlera et al., 2017. P. maniculatus has been successfully infected with the SARS-CoV-2 virus by the respiratory route, but the infected animals displayed only mild pathology, manifested little if any disability, and recovered within a few days Fagre et al., 2021; Griffin et al., 2021. Among natural populations and in the laboratory, P. maniculatus is noted for its tolerance of hantavirus, which commonly is fatal for infected humans Botten et al., 2000; Childs et al., 1994. P. maniculatus was permissive of infection with monkeypox virus, but the infection was mild and transient Deschambault et al., 2023.

A distinguishing P. leucopus characteristic, which was not expressly examined here, is its aforementioned two- to threefold greater life span than that of M. musculus. While deermice may not be in the same longevity league as the naked mole-rat (Heterocephalus glaber), which can live for over 30 years Oka et al., 2023, some features of naked mole-rat immunology are intriguingly similar to what we have observed for P. leucopus. These include macrophages and blood myeloid cells with low to absent transcription of Nos2 or production of nitric oxide in response to LPS, even in the presence of added interferon-gamma Gorshkova et al., 2023. Like P. leucopus and in distinction to M. musculus, naked mole-rats showed an increase in the proportion of neutrophils in the blood 4 hr after intraperitoneal injection of LPS Hilton et al., 2019. In another comparative study, the hematopoietic stem and progenitor cells of these rodents had a lower type 1 interferon response than mice to a TLR3 agonist Emmrich et al., 2022.

In summary, if there is a vulnerability that Peromyscus accepts in return for relief from inflammation (and perhaps a longer life), it has not been identified yet. However, potential threats and stressors are many, and the number assessed either in the field or laboratory has been limited to date.

Implications for Lyme disease and other zoonoses

Our studies of P. leucopus began with a natural population and documented a>80% prevalence of infection and high incidence of re-infections by B. burgdorferi in the area’s white-footed deermouse, the most abundant mammal there (Bunikis et al., 2004). This was a Lyme disease endemic area (Brinkerhoff et al., 2012), where residents frequently presented for medical care for a variety of clinical manifestations, from mild to serious, of B. burgdorferi infection (Steere et al., 1986). Subclinical infections in humans occur, but most of those who become infected have a definable illness (Steere et al., 1998). The localized or systemic presence of the microbe is a necessary condition for Lyme disease, but the majority of the symptoms and signs are attributable to inflammation elicited by the organism’s presence and not from virulence properties per se or the hijacking of host cells (Coburn et al., 2022). Since humans are transmission dead-ends for B. burgdorferi and many other zoonotic agents in their life cycles, it is not surprising that human infections are generally more debilitating if not fatal than what adapted natural hosts experience.

It is in the space between the asymptomatic natural host and symptomatic inadvertent host where there may be insights with basic and translational application. With this goal, we consider the ways the results inform studies of the pathogenesis of Lyme disease, where ‘disease’ includes lingering disorders akin to ‘long Covid’ (Nathan, 2022), and where ‘pathogenesis’ includes both microbial and host contributions. Plausibly germane deermouse-mouse differences identified in our studies are summarized in Figure 13. Two are highlighted here.

Summary of distinguishing features of transcriptional responses in the blood between Peromyscus leucopus and Mus musculus 4 hr after treatment with LPS.

There is semi-quantitative representation of relative transcription of selected coding sequences or ratios of transcription for selected pairs of genes in the blood.

The first is macrophage polarization (Murray, 2017). By the criteria summarized above, the response to LPS by P. leucopus is consistent with the alternatively-activated or M2 type, rather than the expected classical or M1 type. But it was not only LPS-treated deermice that had this attribute, the blood of untreated animals also displayed M2 type polarization features. This included a comparatively high Arg1 expression level and a Akt1/Akt2 transcription ratio of more than 1 at baseline. This suggests that studies of other mammals, including humans, need not administer LPS or other TLR agonist to assess disposition toward M1 or M2-type polarization. This reading could serve as a prognostic indicator of the inflammatory response to infection with B. burgdorferi or other pathogen and the long-term outcome.

The second difference we highlight is the activation of ERV transcription that was prominent in the LPS-treated mice and rats but not in similarly-treated deermice. A paradoxical enlistment of antiviral defenses, including type 1 and type 2 interferons, for an infection with an extracellular bacterium, like B. burgdorferi, may bring about more harm than benefit, especially if the resultant inflammation persists after antibiotic therapy. There are various ways to assess ERV activation in the blood, including assays for RNA, protein, and reverse transcriptase activity. A xenotropic MLV-related retrovirus has been discounted as a cause of chronic fatigue syndrome (McClure and Kaye, 2010). However, production of whole virions need not occur for there to be PRR signaling in response to cytoplasmic Env protein, single stranded RNA, or cDNA (Russ and Iordanskiy, 2023).


Key resources table
Reagent type (species) or resourceDesignationSource or referenceIdentifiersAdditional information
Strain, strain background (Peromyscus leucopus)Outbred LL stock; adults of both sexesPeromyscus Genetic Stock Center of the University of South Carolina
Strain, strain background (Mus musculus)Outbred CD-1 breed; adults of both sexesCharles River LaboratoriesCrl:CD1(ICR) IGS
Strain, strain background (Rattus norvegicus)Inbred Fischer F344 strain; adult femalesCharles River LaboratoriesF344/NHsd
Strain, strain background (Borrelia hermsii)Genomic group II, strain MTWBalderrama-Gutierrez et al., 2021 (reference 3)Provided by Tom Schwan, Rocky Mountain Laboratories
Sequence-based reagentArg1_F for P. leucopusThis paperPCR primerTCCGCTGACAACCAACTCTG
Sequence-based reagentArg1_R for P. leucopusThis paperPCR primerGACAGGTGTGCCAGTAGATG
Sequence-based reagentArg1_F for M. musculusThis paperPCR primerTGTGAAGAACCCACGGTCTG
Sequence-based reagentArg1_R for M. musculusThis paperPCR primerACGTCTCGCAAGCCAATGTA
Sequence-based reagentNos2_F for P. leucopus and M. musculusBalderrama-Gutierrez et al., 2021 (reference 3)PCR primerGACTGGATTTGGCTGGTCCC
Sequence-based reagentNos2_R for P. leucopus and M. musculusBalderrama-Gutierrez et al., 2021 (reference 3)PCR primerGAACACCACTTTCACCAAGAC
Sequence-based reagentGapdh_F for P. leucopus and M. musculusBalderrama-Gutierrez et al., 2021 (reference 3)PCR primerTCACCACCATGGAGAAGGC
Sequence-based reagentGapdh_R for P. leucopus and M. musculusBalderrama-Gutierrez et al., 2021 (reference 3)PCR primerGCTAAGCAGTTGGTGGTGCA
Commercial assay or kitInvitrogen Mouse RiboPure-Blood RNA Isolation KitInvitrogenAM1951
Commercial assay or kitTruSeq Stranded mRNA kit for cDNAIllumina20020594
Commercial assay or kitPower Sybr Green RNA-to-Ct 1-Step Kit for RT-qPCRApplied BiosystemsThermoFisher 4389986
Chemical compound, drugLipopolysaccharide, Escherichia coli O111:B4, ion-exchange chromatography purifiedSigma-AldrichL3024
Chemical compound, drugLipopolysaccharide, Escherichia coli O111:B4, cell culture grade”Sigma-AldrichL4391
Chemical compound, drug0.9% sodium chloride sterile-filtered, endotoxin-testedSigma-AldrichS8776
Software, algorithmFastQC, version 0.12.0Babraham Bioinformatics
Software, algorithmTrimmomatic, version; Usadel and Bolger, 2023
Software, algorithmCLC Genomics Workbench, version 23.1Qiagen
Software, algorithmEnrichR (Enrichment of Gene Ontology)Metascape
Software, algorithmSYSTAT, version 13.1Systat Software, Inc
Software, algorithmFalse Discovery Rate Online CalculatorCarbocation Corporation


The study was carried out in accordance with the Guide for the Care and Use of Laboratory Animals: Eighth Edition of the National Academy of Sciences, and according to ARRIVE Guidelines ( The protocols AUP-18–020 and AUP-21–007 were approved by the Institutional Animal Care and Use Committee of the University of California Irvine.

Peromyscus leucopus, here also referred to as ‘deermice’, were of the outbred LL stock, which originated with 38 animals captured near Linville, NC, and thereafter comprised a closed colony without sib-sib matings at the Peromyscus Genetic Stock Center at the University of South Carolina (Joyner et al., 1998). LL stock animals for this study were bred and raised at the vivarium of University of California Irvine, an AAALAC approved facility. Outbred Mus musculus breed CD-1 (Crl:CD1(ICR) IGS), and here also referred to as ‘mice’, were obtained from Charles River Laboratories. Fischer F344 strain inbred Rattus norvegicus (F344/NHsd), here also referred to as “rats”, were obtained from Charles River Laboratories. Facility acclimatization was for at least 1 week before study.

For the combined P. leucopus-M. musculus experiment, the 20 P. leucopus were of a mean (95% confidence interval) 158 (156-159) days of age and had a mean 21 (19-22) g body mass. The 20 M. musculus were all 149 days of age and had a mean body mass of 47 (43-50) g. The ratio of average male to average female body mass was 1.04 for P. leucopus and 1.03 for M. musculus. The six female P. leucopus for the 12 hr duration experiment were of a mean 401 (266-535) days of age and mean body mass of 20 (17-23) g. The 16 adult 10- to 12-week-old female R. norvegicus had a mean 139 (137-141) g body mass. The seven male P. leucopus for the infection study were of a mean 107 (80-134) days and mean body mass of 21 (18-24) g.

Animals were housed in Techniplast-ventilated cages in vivarium rooms with a 16 h-8 h light-dark cycle, an ambient temperature of 22 °C, and on ad libitum water and a diet of 2020 X Teklad global soy protein-free extruded rodent chow with 6% fat content (Envigo, Placentia, CA).

For all injections, the rodents were anesthetized with inhaled isoflurane. The rodents were euthanized by carbon dioxide overdose and intracardiac exsanguination at the termination of the experiment. No animals died or became moribund before the 4 hr or 12 hr termination time points in the LPS experiments or before the 5 d termination point of infection study.

LPS and infection model experiments

For the P. leucopus and M. musculus combined experiment, sample sizes replicated the specifications of the previous study, in which there were 20 P. leucopus and 20 M. musculus, equally divided between females and males and equally allotted between conditions (Balderrama-Gutierrez et al., 2021). The treatments were administered in the morning of a single day. At 15 min intervals and alternating between species, sex, and treatments, animals were intraperitoneally (ip) injected 50 µl volumes of either ion-exchange chromatography-purified Escherichia coli O111:B4 LPS (Sigma-Aldrich L3024) in a dose of 10 µg per g body mass or the diluent alone: sterile-filtered, endotoxin-tested, 0.9% sodium chloride (Sigma-Aldrich). The animals were visually monitored in separate cages continuously for the duration of the experiment. We recorded whether there was reduced activity by criterion of huddling with little or movement for >5 min, ruffled fur or piloerection, or rapid respiration rate or tachypnea. At 4.0 hr time after injection animals were euthanized as described above, and sterile dissection was carried out immediately.

Lower dose and longer duration experiment. In an experiment with six P. leucopus, the animals were administered the same single dose of LPS but at 1.0 µg/g and the same control solution. The animals were euthanized 12 hr after the injection the following day.

Rat LPS experiment. The same experimental design was used for the rats as for the combined deermice-mice experiment, with the exception that the formulation of the E. coli O111:B4 LPS was ‘cell culture grade’ (Sigma-Aldrich L4391), and the groups were sterile saline alone (n=5), 5 µg LPS per g body mass (n=6), or 20 µg LPS per g (n=5).

Experimental infection

The infection of a group of P. leucopus LL stock with the relapsing fever agent B. hermsii and the processing of blood and tissues for RNA extraction 5 days into the infection were described previously (Balderrama-Gutierrez et al., 2021). In brief, animals were infected intraperitoneally on day 0 with either phosphate-buffered saline alone or 103 cells of B. hermsii MTW, a strain that is infectious for Peromyscus species (Johnson et al., 2016). Bacteremia was confirmed by microscopy on day 4, and the animals were euthanized on day 5. For that prior study the RNA-seq analysis was limited to the genome-wide transcript reference set. For the present study we used the original fastq format files for targeted RNA-seq as described below.

Hematology and plasma analyte assays

For the combined P. leucopus-M. musculus experiment, automated complete blood counts with differentials were performed at Antech Diagnostics, Fountain Valley, CA on a Siemens ADVIA 2120i with Autoslide hematology instrument with manual review of blood smears by a veterinary pathologist. For the 12 hr duration P. leucopus experiment, hematologic parameters were analyzed on an ABCVet Hemalyzer automated cell counter instrument at U.C. Irvine. For the rat experiment, complete blood counts with differentials were performed at the Comparative Pathology Laboratory of the University of California Davis. Multiplex bead-based cytokine protein assay of the plasma of the rats was performed at Charles River Laboratories using selected options of the Millipore MILLIPLEX MAP rat cytokine/chemokine panel.

RNA extraction of blood

After the chest cavity was exposed, cardiac puncture was performed through a 25 gauge needle into a sterile 1 ml polypropylene syringe. After the needle was removed, the blood was expelled into Becton-Dickinson K2E Microtainer Tubes, which contained potassium EDTA. Anticoagulated blood was split into a sample that was placed on ice for same-day delivery to the veterinary hematology laboratory and a sample intended for RNA extraction which was transferred to an Invitrogen RiboPure tube with DNA/RNA Later and this suspension was stored at –20 °C. RNA was isolated using the Invitrogen Mouse RiboPure-Blood RNA Isolation Kit. RNA concentration was determined on a NanoDrop microvolume spectrophotometer (ThermoFisher) and quality was assessed on an Agilent Bioanalyzer 2100.

RNA-seq of blood

The chosen sample sizes and coverage for the bulk RNA-seq were based on empirical data from the prior study (Balderrama-Gutierrez et al., 2021), which indicated that with 10 animals per group and a two-sided two sample t-test we could detect with a power of ≥0.80 and at a significance level of 0.05 a ≥1.5-fold difference in transcription between groups for a given gene. We also were guided by the simulations calculations of Hart et al., 2013, which indicated for a biological coefficient of variation of 0.4 within a group, a minimum depth of coverage of ≥10, and a target of ≥2 x fold change that a sample size of 7–8 was sufficient for 80% power and type I error of 5%. For the P. leucopus and M. musculus samples production of cDNA libraries was with the Illumina TruSeq Stranded mRNA kit. After normalization and multiplexing, the libraries were sequenced at the University of California Irvine’s Genomic High Throughput Facility on a Illumina NovaSeq 6000 instrument with paired-end chemistry and 150 cycles to achieve ~100 million reads per sample for the combined P. leucopus-M. musculus experiment. The same method for producing cDNA libraries was used for the R. norvegicus RNA and the P. leucopus in the infection study, but these were sequenced on a Illumina HiSeq 4000 instrument with paired-end chemistry and 100 cycles. The quality of sequencing reads was analyzed using FastQC (Babraham Bioinformatics). The reads were trimmed of low-quality reads (Phred score of <15) and adapter sequences, and corrected for poor-quality bases using Trimmomatic (Bolger et al., 2014).

For the combined species experiment, the mean (95% CI) number of PE150 reads per animal after trimming for quality was 1.1 (1.0–1.2) x 108 for P. leucopus and 1.1 (1.0–1.2) x 108 for M. musculus (p=0.91). For P. leucopus of this experiment, a mean of 83% of the reads mapped to the genome transcript reference set of 54,466; mean coverages for all transcripts and for the mean 62% of reference transcripts with ≥1 x coverage were 97 x and 157 x, respectively. For M. musculus of this experiment, a mean 91% of the reads mapped to the genome transcript reference set of 130,329; mean coverages for all transcripts and for the mean of 21% of reference transcripts with ≥1 x coverage were 103 x and 568 x, respectively. For the lower dose-longer duration experiment with P. leucopus the mean number of PE150 reads was 2.5 (2.3–2.6) x 107. For the rat experiment, the mean number of PE100 reads was 2.4 (2.2–2.5) x 107. The PE100 Illumina reads from the B. hermsii infection of P. leucopus study (Balderrama-Gutierrez et al., 2021) are from BioProject PRJNA508222, which includes SRA accession numbers (SRR8283809 and SRR8283811-SRR8283816); the mean number of reads was 4.9 (4.5–5.3) x 107.

Batched fastq files were subjected to analysis with CLC Genomics Workbench version 23 (Qiagen). Library size normalization was done by the TMM (trimmed mean of M values) method of Robinson and Oshlack, 2010. The reference genome transcript sets on GenBank were the following: GCF_004664715.2 for P. leucopus LL stock, GCF_000001635.27_GRCm39 for M. musculus C57Bl/6, and GCF_015227675.2_mRatBN7.2 for R. norvegicus. The settings for PE150 reads were as follows for both strands: length fraction of 0.35, similarity fraction of 0.9, and costs for mismatch, insertion, or deletion of 3. For PE100 reads, the settings were the same except for length fraction of 0.4. Principal Component Analysis was carried with the ‘PCA for RNA-Seq’ module of the CLC Genomics Workbench suite of programs.

For the P. leucopus RNA-seq analysis, there were 54,466 reference transcripts, of which 48,164 (88%) were mRNAs with protein coding sequences, and 6302 were identified as non-coding RNAs (ncRNA). Of the 48,164 coding sequences, 40,247 (84%) had matching reads for at least one of the samples. The five most highly represented P. leucopus coding sequences among the matched transcripts of whole blood among treated and control animals were for hemoglobin subunits alpha and beta, the calprotectin subunits S100A8 and S100A9, and ferritin heavy chain. For the M. musculus analysis there were available 130,329 reference transcripts: 92,486 (71%) mRNAs with protein coding sequences and 37,843 ncRNAs. Of the coding sequences, 59,239 (64%) were detectably transcribed in one or both groups by the same criterion. The five most highly represented coding sequences of mRNAs of identified genes for M. musculus were for hemoglobin subunits alpha and beta, aminolevulinic synthase 2, ferritin light polypeptide 1, and thymosin beta. For R. norvegicus, there were 99,126 reference transcripts, of which 74,742 (75%) were mRNAs. The five most highly represented coding sequences of mRNAs of identified genes for R. norvegicus were for hemoglobin subunits alpha and beta, beta-2 microglobulin, ferritin heavy chain, and S100A9.

Genome-wide differential gene expression

Differential expression between experimental conditions was assessed with an assumption of a negative binomial distribution for expression level and a separate Generalized Linear Model for each (McCarthy et al., 2012). Fold changes in TPM (transcripts per million) were log2-transformed. The False Discovery Rate (FDR) with corrected p value was estimated by the method of Benjamini and Hochberg, 1995. To assess the limit of detection for differentially expressed genes between 10 animals treated with LPS and 10 with saline alone, we took the data for 4650 reference transcripts for which the mean TPM across 20 P. leucopus was >10 and randomly permuted the data to achieve another 9 sets and calculated the fold-change of sub-groups of 10 and 10 with one random group serving as the proxy of the experimental treatment and other second as the control for each of the sets. The expectation was that mean fold-change of the 9 permuted sets and the 4650 reference sequences would be ~1. The result was a mean and median of 1.08 with a 99.9% asymmetric confidence interval for the mean of 0.81–1.49. This was an indication that the choices for sample sizes were realistic for achieving detection of ≥1.5 x fold changes.

Gene Ontology term analysis

M. musculus was selected as the closest reference for the P. leucopus data. The analysis was implemented for data for differentially expressed genes meeting the criteria of a FDR P-value ≤0.01 and fold-change of ≥1.5. The analysis was implemented with the tools of Metascape (; Zhou et al., 2019). Functional enrichment analysis was carried out first with the hypergeometric test and FDR p-value correction (Benjamini and Hochberg, 1995). Then pairwise similarities between any two enriched terms were computed based on a Kappa-test score (Cohen, 1960). Similarity matrices were then hierarchically clustered and a 0.3 similarity threshold was applied to trim resultant trees into separate clusters. The lower the p-value, the less the likelihood the observed enrichment is due to randomness (Zar, 1999). The lowest p-value term represented each cluster shown in the horizontal bar graph. Besides the terms beginning with ‘GO’ and referring to the Gene Ontology resource (; Ashburner et al., 2000), others refer to Kegg Pathway database ( for ‘mmu.’ designations, WikiPathways database ( for ‘WP…’ designations, and Reactome database ( for ‘R-MMU…’ designations.

Targeted RNA-seq

RNA-seq of selected set of protein coding sequences (CDS), which are listed below, was carried out using CLC Genomics Workbench v. 23 (Qiagen). Paired-end reads were mapped with a length fraction of 0.35 for ~150 nt reads and 0.40 for ~100 nt reads, a similarity fraction of 0.9, and costs of 3 for mismatch, insertion, or deletion to the CDS of sets of corresponding orthologous mRNAs of P. leucopus, M. musculus, and R. norvegicus. Preliminary expression values were unique reads normalized for total reads across all the samples without adjustment for reference sequence length, as described (Balderrama-Gutierrez et al., 2021). Exceptions were the endogenous retrovirus coding sequences which differed in lengths between species. For within- and cross-species comparisons, we initially normalized three different ways after quality filtering and removing vector and linker sequence: for total reads for the given sample, for unique reads for 12 S ribosomal RNA for the mitochondria of nucleated cells in the blood, and for unique reads for the gene Ptprc, which encodes CD45, a marker for both granulocytes and mononuclear cells in the blood. This is described in more detail in Results. Following the recommendation of Hedges et al. we used the natural logarithm (ln) of ratios (Hedges et al., 1999).

The target CDS were as follows: Acod1, Akt1, Akt2, Arg1, Bcl3, Camp, Ccl2, Ccl3, Ccl4, Cd14, Cd177, Cd3d, Cd4, Cd69, Cd8, Cfb, Cgas, Csf1, Csf1r, Csf2, Csf3, Csf3r, Cx3cr1, Cxcl1, Cxcl10, Cxcl2, Cxcl3, Dhx58, Fcer2, Fcgr2a, Fcgr2b, Fcgr3, Fgr, Fos, Fpr2, Gapdh, Gbp4, Glrx, Gzmb, Hif1a, Hk3, Hmox1, Ibsp, Icam, Ifih1, Ifit1, Ifng, Il10, Il12, Il18, Il1b, Il1rn, Il2ra, Il4ra, Il6, Il7r, Irf7, Isg15, Itgam, Jak1, Jak2, Jun, Lcn2, Lpo, Lrg, Lrrk2, Ltf, Mapk1, Mmp8, Mmp9, Mpo, MT-Co1, Mt2, Mtor, Mx2, Myc, Myd88, Ncf4, Nfkb1, Ngp, Nos2, Nox1, Nr3c1, Oas1, Olfm4, Padi4, Pbib, Pkm, Ptx, Ptprc, Retn, Rigi (Ddx58), S100a9, Saa3, Serpine1, Slc11a1, Slpi, Socs1, Socs3, Sod2, Stat1, Stat2, Stat4, Steap1, Sting, Tgfb, Thy1, Timp1, Tlr1, Tlr2, Tlr4, Tnf, Tnfrsf1a, and Tnfrsf9. The sources for these coding sequences were the reference genome transcript sets for P. leucopus, M. musculus, and R. norvegicus listed above. If there were two or more isoforms of the mRNAs and the amino acid sequences differed, the default selection for the coding sequence was the first listed isoform. The lengths of the orthologous pairs of P. leucopus and M. musculus coding sequences were either identical or within 2% of the other. Fcgr1, the gene for high affinity Fc gamma receptor I or CD64, was not included in the comparison, because in P. leucopus it is an untranscribed pseudogene (Barbour et al., 2023). For the targeted RNA-seq of blood of deermice infected with B. hermsii (Table 5), the reference sequence was the cp6.5 plasmid of B. hermsii (NZ_CP015335).

Quantitative PCR assays

Reverse transcriptase (RT)-qPCR assays and the corresponding primers for measurement of transcripts of genes for nitric oxide synthase 2 (Nos2) and glyceraldehyde 3-phosphate dehydrogenase (Gapdh) were those described previously (Balderrama-Gutierrez et al., 2021). These primers worked for M. musculus as well as P. leucopus using modified cycling conditions. For the Arg1 transcript assays different primer sets were used for each species. The forward and reverse primer sets for the 352 bp Arg1 product for P. leucopus were 5’-TCCGCTGACAACCAACTCTG and 5’-GACAGGTGTGCCAGTAGATG, respectively. The corresponding primer pairs for a 348 bp Arg1 of M. musculus were 5’-TGTGAAGAACCCACGGTCTG and 5’-ACGTCTCGCAAGCCAATGTA. cDNA synthesis and qPCR were achieved with a Power Sybr Green RNA-to-Ct 1-Step Kit (Applied Biosystems) in 96 MicroAmp Fast Reaction Tubes using an Applied Biosystems StepOne Plus real-time PCR instrument. The initial steps for all assays were 48 °C for 30 min and 95 °C for 10 min. For Arg1 and Nos2 assays, this was followed by 40 cycles of a 2-step PCR of, first, 95 °C for 15 s and then, second, annealing and extension at 60 °C for 1 min. The cycling conditions for Gapdh were 40 cycles of 95 °C for 15 s followed by 60 °C for 30 s. Quantitation of genome copies of B. hermsii in extracted DNA was carried out by probe-based qPCR as described (Barbour et al., 2009).

Additional statistics

Means are presented with asymmetrical 95% confidence intervals (CI) to accommodate data that was not normally distributed. Parametric (t test) and non-parametric (Mann-Whitney) tests of significance were two-tailed. Unless otherwise stated, the t test p value is given. Categorical variables were assessed by two-tailed Fisher’s exact test. FDR correction of p values for multiple testing was by the Benjamini-Hochberg method (Benjamini and Hochberg, 1995), as implemented in CLC Genomics Workbench (see above), or False Discovery Rate Online Calculator ( Discriminant Analysis, linear regression, correlation, coefficient of determination, and General Linear Model analyses were performed with SYSTAT v. 13.1 software (Systat Software, Inc). Box plots with whiskers display the minimum, first quartile, median, third quartile, and maximum.

Data availability

Sequencing data as fastq files of Illumina reads (SRA), along with descriptions of the samples (BioSamples) they are associated with, have been deposited with NCBI under BioProjects PRJNA975149, PRJNA874306, and PRJNA973677. The Transcriptome Shotgun Assembly of the blood of Peromyscus leucopus and produced for this study has TSA accession number GKOE00000000.1.All the data generated and analyzed for this study are included in the manuscript and supporting files. Source Data files have been provided for all figures except Figure 1, the data for which are provided in Table 1.

The following data sets were generated
    1. University of California Irvine
    (2023) NCBI BioProject
    ID PRJNA975149. Transcriptomes of whole blood of outbred Peromyscus leucopus and Mus musculus in response to lipopolysaccharide.
    1. University of California Irvine
    (2022) NCBI BioProject
    ID PRJNA874306. Peromyscus leucopus transcriptome in response to TLR agonists.
    1. University of California Irvine
    (2023) NCBI BioProject
    ID PRJNA973677. Transcriptomes of blood of Rattus norvegicus in response to lipopolysaccharide.
    1. University of California Irvine
    (2023) NCBI Nucleotide
    ID GKOE00000000.1. Transcriptome shotgun assembly of whole blood of female and male Peromyscus leucopus with and without treatment with lipopolysaccharide.
The following previously published data sets were used
    1. University of California Irvine
    (2018) NCBI BioProject
    ID PRJNA508222. Peromyscus leucopus transcriptome of Borrelia hermsii-infected and uninfected animals.


  1. Book
    1. Barbour AG
    In: Whitman WB, Rainey RP, Kämpfe P, Trujillo M, Chun J, DeVos P, Hedlund B, Dedysh S, editors. Bergey’s Manual of Systematics of Archaea and Bacteria. Hoboken, NJ, USA: Wiley. pp. 1–9.
    1. Bothwell A
    2. Pace PE
    3. LeClair KP
    Isolation and expression of an IFN-responsive Ly-6C chromosomal gene
    Journal of Immunology 140:2815–2820.
  2. Book
    1. Bradley RD
    2. Ammerman LK
    3. Baker RJ
    4. Bradley LC
    5. Cook JA
    6. Dowler RC
    7. Jones C
    8. Schmidly DJ
    9. Stangl FB
    10. Den Bussche RA
    Revised Checklist of North American Mammals North of Mexico
    Museum of Texas Tech University; 2014.
  3. Book
    1. Hall ER
    Mammals of North America
    John Wiley and Sons.
    1. Sacher GA
    2. Hart RW
    Longevity, aging and comparative cellular and molecular biology of the house mouse, Mus musculus, and the white-footed mouse, Peromyscus leucopus
    Birth Defects Original Article Series 14:71–96.
    1. Soudi S
    2. Zavaran-Hosseini A
    3. Muhammad Hassan Z
    4. Soleimani M
    5. Jamshidi Adegani F
    6. Hashemi SM
    Comparative study of the effect of LPS on the function of BALB/c and C57BL/6 peritoneal macrophages
    Cell Journal 15:MC3660024.
    1. Wiedmeyer CE
    2. Crossland JP
    3. Veres M
    4. Dewey MJ
    5. Felder MR
    6. Barlow SC
    7. Vrana PB
    8. Szalai G
    Hematologic and serum biochemical values of 4 species of Peromyscus mice and their hybrids
    Journal of the American Association for Laboratory Animal Science 53:336–343.
  4. Book
    1. Zar JH
    Biostatistical Analysis
    Prentice Hall.

Peer review

Reviewer #1 (Public Review):


o A well-executed series of experiments that will likely be of immense interest to (a) vector-borne disease researchers and (b) gram-negative sepsis/bacteremia researchers. The study uses comparative transcriptomics to begin probing what makes Peromyscus leucopus a unique host for numerous pathogens across the tree of life. Authors responded well to concerns raised in peer review and have produced an excellent second version of the manuscript.


o Use of outbred M. musculus is a commendable choice for the studies here.

o Use of both LPS and B. hermsii allows analysis of multiple different signaling pathways that may differ between the species.

o Upload of analyzed data onto Dryad is appreciated.


o None noted beyond the authors own limitation discussion section

Reviewer #2 (Public Review):

Milovic, Duong, and Barbour investigate the inflammatory response of three species of small mammals (P. leucopus, M. musculus, and R. norvegicus) to endotoxin lipopolysaccharide (LPS) injection via genome-wide transcriptomics from blood samples. Understanding the inflammation response of P. leucopus is of importance as they are a reservoir for several pathogens. The study is a thorough, controlled, well researched analysis that will be valuable for designing and interpreting future studies. The authors discuss the limitations of the data and the potential directions. Clearly P. leucopus respond differently to the LPS exposure which is very interesting and opens the door for numerous other comparative studies.

The conclusions of the manuscript are thoughtful and supported by the data. The authors addressed my questions about mouse numbers, sex differences, and the presentation of Nos2 and Arg1 data.

Author response

The following is the authors’ response to the original reviews.

Re: Revised author response for eLife-RP-RA-2023-90135 (“The white-footed deermouse, an infection-tolerant reservoir for several zoonotic agents, tempers interferon responses to endotoxin in comparison to the mouse and rat” by Milovic, Duong, and Barbour”)

The revised manuscript has taken into account all the comments and questions of the two reviewers. Our responses to each of the comments are detailed below. In brief, the modifications or additional materials for the revision each specifically address a reviewer comment. These modifcations or materials include the following….

• a more in-depth consideration of sample sizes

• a better explanation of what p values signify for a GO term analysis

• a more detailed account of the selection of the normalization procedure for cross-species targeted RNA-seq (including a new supplemental figure)

• several more box plots in supplementary materials to complement the scatterplots and linear regressions of the figures of the primary text

• provision in a public access repository of the complete data for the RNA-seq analyses as well as primary data for figures and tables as new supplementary tables

• the expansion of description of the analysis done for the revision of Borrelia hermsii infection of P. leucopus. This included a new table (Table 10 of the revision) • development of the possible relevance of finding for longevity studies by citing similarities of the findings in P. leucopus with those in the naked mole-rat

• what we think is a better assessment of differences between female and male P. leucopus for this particular study, while still keeping focus on DEGs in common for females and males. This included a new figure (Figure 4 of the revision).

• removal of reference to a “inverse” relationship between Nos2 and Arg1 while still retaining ratios of informative value

We note that in the interval between uploading the original bioRxiv preprint and now we learned of the paper of Gozashti, Feschotte, and Hoekstra (reference 32), which supports our conception of the important place of endogenous retroviruses in the biology and ecology of deermice. This is the only addition or modification that was not a direct response to a reviewer comment or question, but it was germane to one of Reviewer #1’s comments (“Regarding..”).

Reviewer #1:

Supplemental Table 1 only lists genes that passed the authors statistical thresholds. The full list of genes detected in their analysis should be included with read counts, statistics, etc. as supplemental information.

We agree that provision of the entire lists of reference transcripts and the RNA-seq results for each of the 40 animals is merited. These datasets are too large for what the journal’s supplementary materials resource was intended for, so we have deposited them at the Dryad public access repository.

While P. leucopus is a critical reservoir for B. burgdorferi, caution should be taken in directly connecting the data presented here and the Lyme disease spirochete. While it's possible that P. leucopus have a universal mechanism for limiting inflammation in response to PAMPs, B. burgdorferi lack LPS and so it is also possible the mechanisms that enable LPS tolerance and B. burgdorferi tolerance may be highly divergent.

The impetus for the study was the phenomenon of tolerance of infection of P. leucopus by a number of different kinds of pathogens, not just B. burgdorferi. We take the reviewer’s point, though. Certainly, the white-footed deermouse is probably most notable at-large for its role as a reservoir for the Lyme disease agent. We doubt that the species responses to LPS and to the principal agonists of B. burgdorferi are “highly divergent”, though. Other than the TLR itself-TLR4 for LPS vs the heterodimer TLR2/TLR1 for the lipoproteins of these spirochetes--the downstream signaling is generally similar for amounts comparable in their agonist potency.

We had thought that we had addressed this distinction for B. burgdorferi and otherBorreliaceae members by referring to the earlier study. But we agree with the reviewer that what was provided on this point was insufficient in the context of the present work. Accordingly, for the revision we have added a new analysis of the data on experimental infection of P. leucopus with Borrelia hermsii, which lacks LPS and for which the TLR agonists eliciting inflammation are lipoproteins. We do this in a format (new Table 6) that aids comparison with the LPS experimental data elsewhere in the article. As the manuscript references, B. burgdorferi infection of P. leucopus elicits comparatively little inflammation in blood even at the height of infection. While this phenomenon with the Lyme disease agent was part of the rationale driving these studies, the better comparison with LPS was 5 days into B. hermsii infection when the animals are spirochetemic.

Statistical significance is binary and p-values should not be used as the primary comparator of groups (e.g. once a p-value crosses the deigned threshold for significance, the magnitude of that p-value no longer provides biological information). For instance, in comparing GO-terms, the reason for using of high p-value cutoffs ("None of these were up-regulated gene GO terms with p values < 1011 for M. musculus.") to compare species is unclear. If the authors wish to compare effect sizes, comparing enrichment between terms that pass a cutoff would likely be the better choice. Similarly, comparing DEG expression by p-value cutoff and effect size is more meaningful than analyses based on exclusively on p-value: "Of the top 100 DEGs for each species by ascending FDR p value." Description in later figures (e.g. Figure 4) is favored.

Effect sizes--in this case, fold-changes--were taken into account for GO term analysis and were specified in the settings that are described. So, any gene that was “counted” for consideration for a particular GO term would have passed that threshold and with a falsediscovery corrected p value of a specified minimum. There is no further scoring of the “hit” based upon the magnitude of the p value beyond that point. It is, as the reviewer writes, binary at that point. We are in agreement on those principles.

As we understand the comment above, though, the p-values referred to are in regard to the GO term analysis itself. The objective was discovery followed by inference. The situation was more like a genome-wide association study (GWAS) study. This is not strictly speaking a hypothesis test, because there was no stated hypothesis ahead of time or one driving the design. The “p value” for something like GO term analysis or GWAS provides an estimate of the strength of the association. It is not binary in that sense. The lower the p value, the greater confidence about the association. In a GWAS of a human population an association of a trait with a particular SNP or indel is usually not taken seriously unless the p value is less than 10^-7 or 10^-8. In the case of GO terms, the p value approximates (but is not equivalent to) the number of genes that are differentially expressed that belong to a GO cluster out of the total number of genes that define that cluster. The higher the proportion of the genes in the cluster that are associated with a treatment (LPS vs. saline), the lower the p value. Thus, it provides information beyond the point at which it would be rightly deemed of little additional value in many hypothesis testing circumstances.

That said, we agree that the original manuscript could have been clearer on this point and have for the revision expanded the description of the GO term analysis in the Methods, including some explanation for a reader on what the p value signifies here. We also refrain from specifying a certain p value for special attention and merely list 20 by ascending p value.

The ability to use of CD45 to normalize data is unclear. Authors should elaborate both on the use of the method and provide some data how the data change when they are normalized. For instance, do correlations between untreated Mus and Peromyscus gene expression improve? The authors seem to imply this should be a standard for interspecies comparison and so it would be helpful to either provide data to support that or, if applicable, use of the technique in literature should be referenced.

The reviewer brings up an important point that we considered addressing in more depth for the original manuscript but in the end deferred to considerations about length and left it out.

But we are glad to address this here, as well as in the revised manuscript.

We did not intend to imply either that this particular normalization approach had been done before by others or that it “should” be a standard. We are not aware of another report on this, and it would be up to others whether it would be useful or not for them. We made no claim about its utility in another model or circumstance. The challenge before us was to do a comparative analysis of transcription in the blood not just for animals of one species under different conditions but animals of two different genera under different conditions. A notable difference between the animals was in their white blood cell counts, as this study documents. White cells would be the source of a majority of transcripts of potential relevance here, but there would also be mRNA for globins, from reticulocytes, from megakaryocytes, and likely cell-free RNA with origins in various tissues. If the white cell numbers differed, but the non-white cell sources of RNA did not, then there could be unacknowledged biases.

It would be like comparing two different kinds of tissues and assuming them to be the same in the types and numbers of cells they contained. Four hours after a dose of LPS the liver cells (or brain cells) would differ in their transcriptional profiles from untreated the livers (or brains) of untreated animals for sure, but there would not be much if any change in the numbers of different kinds of cells in the liver (or brain) within 4 hours. The blood can change a lot in composition within that time frame under these same conditions. Some sort of accounting for differing white cell numbers in the blood in different outbred animals of two species seemed to be called for.

The normalization that was done for the genome-wide analysis was not based on a particular transcript, but instead was based on the total number of reads, the lengths of the reference transcripts, and the distributions of reads matching to the tens of thousands of references for each sample. This was done according to what are standard procedures by now for bulk RNAseq analyses. Because the reference transcript sets for P. leucopus and M. musculus differed in their numbers and completeness of annotation, we did not attempt any cross-species comparison for the same set of genes at that point. That would not be possible because they were not entirely commensurate.

The GO term analysis of those results provided the leads for the more targeted approach, which was roughly analogous to RT-qPCR. For a targeted assay of this sort, it is common to have a “housekeeping gene” or some other presumably stably transcribed gene for normalization. A commonly used one is Gapdh, but we had previously found that Gapdh was a DEG itself in the blood in P. leucopus and M. musculus at the four hour mark after LPS. The aim was to provide for some adjustment so datasets for blood samples differing in white blood cell counts could be compared. Two options were the 12S ribosomal RNA of the mitochondria, which would be in white cells but not mature erythrocytes, and CD45, which has served an approximately similar function for flow cytometry of the blood. As described in what has been added for the revision and the supplementary materials, we compared these different approaches to normalization. Ptprc and 12S rRNA were effectively interchangeable as the denominator with identifying DEGs of P. leucopus and M. musculus and cross-species comparisons.

Regarding the ISG data-is a possible conclusion not that Peromyscus don't upregulate the antiviral response because it's already so high in untreated rodents? It seems untreated Peromyscus have ISG expression roughly equivalent to the LPS mice for some of the genes. This could be compared more clearly if genes were displayed as bar plots/box and whisker plots rather than in scatter plots. It is unclear why the linear regression is the key point here rather than normalized differences in expression.

In answer to the question: yes, that is possible. In the interval between uploading of the manuscript and this revision, we became aware of a study by Gozashti and Hoekstra published this year in Molecular Biology and Evolution (reference 32) and reporting on the “massive invasion” of endogenous retroviruses in P. maniculatus and the defenses deployed in response to achieve silencing. We cite this work and discuss it, including related findings for P. leucopus, in the revision.

We had originally intended to include box plots as well as scatterplots with regressions for the data, but thought it would be too much and possibly considered redundant. But with this encouragement from the reviewer we provide additional box plots in supplementary materials for the revision.

Some sections of the discussion are under supported:

The claim that low inflammation contributes to increased lifespan is stated both in the introduction and discussion. Is there justification to support this? Do aged pathogen-free mice show more inflammation than aged Peromyscus?

We respectively point out that there was not a claim of this sort. We stated a fact about P. leucopus’ longevity. We made no statement connecting longevity and inflammation beyond the suggestion in the introduction that the explanation(s) for infection tolerance might have some bearing for studies on determinants of life span.

But the reviewer’s comment prompted further consideration of this aspect of Peromyscus biology. This led eventually to the literature on the naked mole-rat, which seems to be the rodent with the longest known life span and the subject of considerable study. The discussion section of the revision has an added paragraph on some of the similarities of P. leucopus and the naked mole-rat in terms of neutrophils, expression of nitric oxide synthase 2 in response to LPS, and type 1 interferon responses. While this is far from decisive, it does serve to connect some of the dots and, hopefully, is considered at least partially responsive to the reviewer’s question.

The claim that reduced Peromyscus responsiveness could lead to increased susceptibility to infection is prominently proposed but not supported by any of the literature cited.

There was not this claim. In fact, it was framed as a question, not a statement. Nevertheless, we think we understand what the comment is getting at and acknowledge in the revision that there may be unexamined circumstances in which P. leucopus may be more vulnerable.

References to B. burgdorferi, which do not have LPS, in the discussion need to ensure that the reader understands this and the potential that responses could be very different.

We think we addressed this comment in a response above.

Reviewer #2:

1. How were the number of animals for each experiment selected? Was a power analysis conducted?

A power analysis of any meaning for bulk RNA-seq with tens of thousands of reference transcripts, each with their own variance, and a comparison of animals of two different genera is not straight forward. Furthermore, a specific hypothesis was not being tested. This was a broad, forward screen. But the question about sample sizes is one that deserves more attention than the original manuscript provided. This now provided in added text in two places in Methods ( “RNA-seq” and “Genome-wide different gene expression”) in the revision.

1. The authors conducted a cursory evaluation of sex differences of P. leucopus and reported no difference in response except for Il6 and Il10 expression being higher in the males than the females in the exposed group. The data was not presented in the manuscript. Nor was sex considered for the other two species. A further discussion of the role that sex could play and future studies would be appreciated.

We agree that the limited analysis of sex differences and the undocumented remark about Il6 and Il10 expression in females and males warranted correction. For the revision we removed that analysis of targeted RNA-seq of P. leucopus from the two different studies. For this study we were looking for differences that applied to both species. This was the reason that there were equal numbers of females and males in the samples. We agree that further investigation of differences between sexes in their responses is of interest but is probably best left for “future studies”.

But in revision we do not entirely ignore the question of sex of the animal and provide an additional analysis of the bulk RNA-seq for P. leucopus with regard to differences between females and males. This basically demonstarted an overall commensurability between sexes, at least for the purposes of the GO term analysis and subsequent targeted RNA-seq, but did reveal some exceptions that are candidate genes for those future studies.

In the revision, we also add for the discussion and its “study limitations” section a disclaimer about possibly missing sex associated differences because the groups were mixed sexes.

1. The ratio of Nos2 and Arg1 copies for LPS treated and control P. leucopus and M. musculus in Table 3 show that in P. leucopus there is not a significant difference but in M. musculus there is an increase in Nos2 copies with LPS treatment. The authors then used a targeted RNA-seq analysis to show that in P. leucopus the number of Arg1 reads after LPS treatment is significantly higher than the controls. These results are over oversimplified in the text as an inverse relationship for Nos2/Arg1 in the two species.

We agree. In addition to providing box plots for Arg1 and Nos2, as suggested by Reviewer #1, we also replaced “ratio” in commenting on Arg1 and Nos2, with “differences in Nos2 and Arg1 expresssion” replacing “ratio of Nos2 to Arg1 expression” at one place. At another place we have removed “inverse” with regard to Nos2 and Arg1. But we respectfully decline to remove Nos2/Arg1 from Figure 5 (now Figure 6) or inclusion of Nos2/Arg1 ratios elsewhere. According to our understanding there need not be an inverse relationship for a ratio to have informative value.

Recommendations For the Authors

We thank the two reviewers for their constructive recommendations and suggestions, in some case pointing out errors we totally missed. For the great majority, the recommendations were followed. Where we decline or disagree we explain this in the response.

Reviewer #1 (Recommendations For The Authors):

• How was the FDR < 0.003 cutoff chosen for DEG? All cutoffs are arbitrary but there should be some justification.

We agree and have provided the rationale at that point in the paper (before Figure 3) in R2:"For GO term analysis the absolute fold-change criterion was ≥ 2. Because of the ~3-fold greater number of transcripts for the M. musculus reference set than the P. leucopus reference set, application of the same false-discovery rate (FDR) threshold for both datasets would favor the labeling of transcripts as DEGs in P. leucopus. Accordingly, the FDR p values were arbitrarily set at <5 x 10-5 for P. leucopus and <3 x 10-3 for M. musculus to provide approximately the same number of DEGs for P. leucopus (1154 DEGs) and M. musculus (1266 DEGs) for the GO term comparison."

• It would be helpful to include a figure demonstrating the correlation between CD45 and WBC ("Pearson's continuous and Spearman's ranked correlations between log-transformed total white blood cell counts and normalized reads for Ptprc across 40 animals representing both species, sexes, and treatments were 0.40 (p = 0.01) and 0.34 (p = 0.03), respectively.")

In both the first version of the revision (R1) and in R2 we provide a fuller explanation of the choice of CD45 (Ptprc) for normalization as detailed in the response to Reviewer #1's public comment. In the revision only Pearson's correlation and p value is given. We did not think another figure was justified after there was additional space devoted to this in both R1 and R2.

• Unclear what the following paragraph is referring to-is this from the previous paper? Was this experiment introduced somewhere? "Low transcription of Nos2 and high transcription of Arg1 both in controls and LPS-treated P. leucopus was also observed in the experiment where the dose of LPS was 1 µg/g body mass instead of 10 µg/g and the interval between injection and assessment was 12 h instead of 4 h (Table 4)."

This experiment is described in the Methods in the original and subsequent versions, but we agree that it is not clear whether it was from present study or previous one. Here is the revised text for R2:"Low transcription of Nos2 in both in controls and LPS-treated P. leucopus and an increase inArg1 with LPS was also observed in another experiment for the present study where the dose of LPS was 1 µg/g body mass instead of 10 µg/g and the interval between injection and assessment was 12 h instead of 4 h (Table 4)."

• Regarding the differences in IFNy between outbred and BALB/c mice-are there any other RNA-seq datasets you can mine where other inbred mice (B/6, C3H, etc) have been injected with LPS and probed roughly the same amount of time later? Do they look like BALB/c or the outbreds?

In both the original and R1 and R2 we cite two papers on the difference of BALB/c mice. While this is of interest for follow-up in the future, we did not think additional content on a subject that mainly pertains to M. musculus was warranted here, where the main focus is Peromyscus.

• Figure 8 and its legend are difficult to follow. The top half of the figure is not well explained and it's unclear what species this is. Decreased use of abbreviations would help. Consider marking each R2 value as Mus or Peromyscus (As done in Fig 9). There are some typographical errors in the legend ("gree,") incomplete sentence missing the words LPS or treatment AND Mus: "Co-variation between transcripts for selected PRRs (yellow) and ISGs (gree) in the blood of P. leucopus (P) or (M) with (L") or without (C)."

This is now Figure 9 in both R1 and R2. We revised it for R1 to include references to the box plots in supplementary materials, but agree with Reviewer #1's recommendation to correct the typos and make the legend less confusing. We did not think that further labeling of the R2 values in the scatterplots with the species names was necessary. The data points are not just colors but also different symbols, so it should be fairly easy for readers to distinguish the regression lines by species. For R2 this is the revised legend with additions in response to the recommendation underlined:

"Figure 9. Co-variation between transcripts for selected PRRs and ISGs in the blood of P. leucopus (P) or M. musculus (M) with (L) or without (C) LPS treatment. Top panel: matrix of coefficients of determination (R2) for combined P. leucopus and M. musculus data. PRRs are indicated by yellow fill and ISGs by blue fill on horizontal and vertical axes. Shades of green of the matrix cells correspond to R2 values, where cells with values less than 0.30 have white fill and those of 0.90-1.00 have deepest green fill. Bottom panels: scatter plots of log-transformed normalized Mx2 transcripts on Rigi (left), Ifih1 (center), and Gbp4 (right). The linear regression curves are for each species. For the right-lower graph the result from the General Linear Model (GLM) estimate is also given. Values for analysis are in Table S4; box plots for Gbp4, Irf7, Isg15,Mx2, and Oas1 are provided in Figure S6."

• Discussion section could benefit from editing for clarity. Examples listed: o Unclear what effect is described here "The bacterial infection experiment indicated that the observed effect in P. leucopus was not limited to a TLR4 agonist; the lipoproteins of B. hermsii are agonists for TLR2 (Salazar et al. 2009)."

Both R1 and R2 include the new section on the B. hermsii infection model. This was added in response to Reviewer #1 public comment. So the expanded consideration of this aspect should address the reviewer's recommendation for more clarity and context here. For R2 we modified the text in the discussion of R1:

"The analysis here of the B. hermsii infection experiment also indicated that the phenomenon observed in P. leucopus was not limited to a TLR4 agonist."

o Unclear what the takeaway from this paragraph is: "Reducing the differences between P. leucopus and the murids M. musculus and R. norvegicus to a single all-embracing attribute may be fruitless. But from a perspective that also takes in the 2-3x longer life span of the whitefooted deer mouse compared to the house mouse and the capacity of P. leucopus to serve as disease agent reservoir while maintaining if not increasing its distribution (Moscarella et al. 2019), the feature that seems to best distinguish the deer mouse from either the mouse or rat is its predominantly anti-inflammatory quality. The presentation of this trait likely has a complex, polygenic basis, with environmental (including microbiota) and epigenetic influences. An individual's placement is on a spectrum or, more likely, a landscape rather than in one or another binary or Mendelian category."

We agree that modification, simplication, and clarification was called for. In response to a public comment of Reviewer #1 we had changed that section, leaving out reference to longevity here.Here is the revised text in both R1 and R2:

"Reducing differences between P. leucopus and murids M. musculus and R. norvegicus to a single attribute, such as the documented inactivation of the Fcgr1 gene in P. leucopus (7), may be fruitless. But the feature that may best distinguish the deermouse from the mouse and rat is its predominantly anti-inflammatory quality. This characteristic likely has a complex, polygenic basis, with environmental (including microbiota) and epigenetic influences. An individual’s placement is on a spectrum or, more likely, a landscape rather than in one or another binary or Mendelian category."

Minor comments:

• Use of blue and red in figures as the -only- way to easily distinguish between groups is a poor choice-both in terms of how inclusivity of color-blind researchers and enabling grayscale printing. Most detrimental in Figure 2, but also slightly problematic in Figure 1. Use of color and shape (as done in other figures) is a much better alternative.

We agree. Both figures have been modified to include an additional characteristic for denoting the data point. For Figure 1 it is a black filling, and for Figure 2 it is the size of symbol in additon to the color. This should enable accurate visualization by color blind individuals and printing in gray scale. We have added definitions for the symbols within the graph itself, so there is no need to refer to the legend to interpret what they mean.

• Note the typo where it should read P leucopus: "The differences between P. musculus and M. musculus in the ratios of Nos2/Arg1 and IL12/IL10 were reported before (BalderramaGutierrez et al. 2021),"

We thank the reviewer for pointing this typo out, which also carried over to R1. It has been corrected for R2.

• Optional: Can the relationship between the ratios in figure 5 and macrophage "types" be displayed graphically alongside the graphs? It's a little challenging to go back and forth between the text and the figure to try to understand the biological implication.

We considered something like this but in the end decided that we were not yet comfortable assigning “types” in this fashion for Peromyscus.

Reviewer #2 (Recommendations For The Authors):

• Be consistent with nomenclature for your species/treatment groups in the text, figures, and tables. For example, you go back and forth between "P. leucopus" and "deermouse" in the text.And in figures you use "P," "Peromyscus", or "Pero".

In the Methods section of the original and revisions R1 and R2 we indicate that "deermouse" is synonymous with "Peromyscus leucopus" and "mouse" is synonymous with "Mus musculus" in the context of this paper. We think that some alternation in the terms relieves the text of some of its repetitiveness and that readers should not have a problem with equating one with the other. The use of "deermouse" also reinforces for readers that Peromyscus is not a mouse. With regard to the abbreviations for P. leucopus, those were used to accommodate design and space issues of the figures or tables. In all cases, the abbreviations referred to are defined in the legends of the figures. So, we respectfully decline to follow this recommendation.

• Often the sentence structure and/or word choice is irregular and makes quick/easy comprehension difficult. Several examples are:

o The third paragraph of the introduction

We agree that the first and second sentences are unclear. Here is the revision for R2:

“As a species native to North America, P. leucopus is an advantageous alternative to the Eurasian-origin house mouse for study of natural variation in populations that are readily accessible (9, 53). A disadvantage for the study of any Peromyscus species is the limited reagents and genetic tools of the sorts that are applied for mouse studies.”

o The first line after Figure 5 on page 9.

We agree. The long sentence which we think the reviewer is referring to has been in split into two sentences for R2.

“An ortholog of Ly6C (13), a protein used for typing mouse monocytes and other white cells, has not been identified in Peromyscus or other Cricetidae family members. Therefore, for this study the comparison with Cd14 is with Cd16 or Fcgr3, which deermice and other cricetines do have.”

o The sentence that starts "Our attention was drawn to..." on page 14.

We agree that the sentence was awkward and split into two sentences.

“Our attention was drawn to ERVs by finding in the genome-wide RNA-seq of LPS-treated and control rats. Two of the three highest scoring DEGs by FDR p value and fold-change were a gagpol polyprotein of a leukemia virus with 131x fold-change from controls and a mouse leukmia virus (MLV) envelope (Env) protein with 62x fold-change (Dryad Table D5).”

• For figures with multiple panels, use (A, B) etc then indicate which panel you are discussing in your text. This is a very data heavy study and your readers can easily get lost.

We agree and have added pointers in the text to the panels we are referring to. But we prefer to use easily understood descriptors like “left” and “upper” over assigned letters.

• For all the figures, where are the stats from the t-tests? Why didn't you do a two-way ANOVA? Instead of multiple t-tests?

Where we are not hypothesis testing and we are able to show all the data points in box-whisker plots with distributions fully revealed, our default position is not to apply significance tests in a post hoc fashion. If a reader or other investigator wants to do this for other purposes, e.g. a meta-analysis, the data is provided in public repository for them to do this. We are not sure what the reviewer means by "multiple t-tests" for "all figures". Where we do 2-tailed t-tests for presentation of data for many genes in a table for the targeted RNA (where individual values cannot shown in the table), there is always correction for multiple testing, as indicated in Methods. The p values shown as "FDR" are after correction.

• Results paragraph "LPS experiment and hematology studies"

o List the two species for the first description to orient the reader since you eventually include rat data.

We agree that this is warranted and followed this recommendation for R2.

o Not all the mice experienced tachypnea, but the text makes it seem like 100% did.

We are not sure what the reviewer is referring to here. This is what is in the text on tachypnea: "By the experiment’s termination at 4 h, 8 of 10 M. musculus treated with LPS had tachypnea, while only one of ten LPS-treated P. leucopus displayed this sign of the sepsis state (p = 0.005)." The only other mention of "tachypnea" was in Methods.

• Figure 1: Why was the M. musculus outlier excluded? Where any other outliers excluded?

That data point for the mouse was not "excluded" from the graph. It is identified (MM17) for reference with Table 1, and there is the graph for all to see where it is. It was only excluded from the regression curve for control mice. There was no significance testing. There were no other outliers excluded.

• Figure 3: explain the colors and make the scales the same for all the panels or at least for the upregulated DEGs and the downregulated DEGs.

We have modified the legend for Figure 3 to include fuller definitions of the x-axes and a description of the color spectrum. We decline to make the x-axis scale the same for all the panels because the horizontal bars in “transcription down” panels would take up only a small fraction of the space. The x-axes are clearly defined and the colors of the bars also indicate the differences in p-values. We doubt that readers will be misled. Here is the revised legend: “Figure 3. Gene Ontology (GO) term clusters associated with up-regulated genes (upper panels) and down-regulated genes (lower panels) of P. leucopus (left panels) and M. musculus (right panels) treated with LPS in comparison with untreated controls of each species. The scale for the x-axes for the panels was determined by the highest -log10 p values in each of the 4 sets. The horizontal bar color, which ranges from white to dark brown through shades of yellow through orange in between, is a schematic representation of the -log10 p values.”

• Results paragraph "Targeted RNA seq analysis"

o In the third paragraph, an R2 of 0.75 is not close enough to 1 to call it "~1"

What the reviewer is referring to is no longer in either R1 and R2, as detailed in the authors' response to public comments.

o In the 4th paragraph, where are your stats?

We have replaced terms like "substantially" and "marginally" with simple descriptions of relationships in the graphs.

"For the LPS-treated animals there was, as expected for this selected set, higher expression of the majority genes and greater heterogeneity among P. leucopus and M. musculus animals in their responses for represented genes. In contrast to the findings with controls, Ifng and Nos2 had higher transcription in treated mice. In deermice the magnitude of difference in the transcription between controls and LPS-treated was less."

• Figure 4: The colors are hard to see, I suggest making all the up regulated reads one color, the down regulated reads a different color, and the reads that aren't different black or gray.

This is now Figure 5 in R1 and R2. The selected genes that are highlighted in the panels are denoted not only by color but also by type of symbol. We do not think that readers will have a problem telling one from another even if color blind. The purpose of this figure was to provide an overview and a visual representation with calling out of selected genes, some of which will be evaluated in more detail later. We thought that this was necessary before diving deeper into the data of Table 2. We do not think further discriminating between transcripts in the categorical way that the reviewer suggests is warranted at this point. So, we respectfully decline to follow this suggestion.

• Results paragraph " Alternatively- activated macrophages...."

o Include a brief description of Nos2 and Arg1

We have defined what enzymes these are genes for in R2.

o How do you explain the lack of a difference in P. leucopus Arg1? Your text says the RT-qPCR confirms the RNA-seq findings.

There was a difference in P. leucopus Arg1 by RT-qPCR between control and LPS treated by about 3-fold. By both RNA-seq and RT-qPCR Arg1 transcription is higher in P. leucopus than in M. musculus under both conditions. But we have modified the sentence so that does not imply more than what the data and analysis of the table reveal.

"While we could not type single cells using protein markers, we could assess relative transcription of established indicators of different white cell subpopulations in whole blood. The present study, which incorporated outbred M. musculus instead of an inbred strain, confirmed the previous finding of differences in Nos2 and Arg1 expression between M. musculus and P. leucopus (Figure 5; Table 2). Results similar to the RNA-seq findings were obtained with specific RT-qPCR assays for Nos2 and Arg1 transcripts for P. musculus and M. musculus (Table 3)."

• Figure 5: reorganize the panels to make the text description and label with letters, where are the stats?

We thought the figure (now Figure 6) was self-explanatory, but agree that further explanation in the legend was indicated. We prefer to use descriptions of locations (“upper left”) over labels, like “panel C”, which do not obviously indicate the location of the panel. Of course, if the journal’s style mandates the other format we will do so. Our response about “stats” for boxplot figures is the same as what we provided above.

• Results paragraph "Interferon-gamma and interleukin-1 beta..."

o Either add the numbers or direct the viewer to where Ifng is in Table 2. The table is very big and Ifng is all the way at the bottom!

We agree that this table is large, but we thought it better to err on the side of inclusiveness by having a single table, rather than have some genes in the main article and other results in a supplementary table. We thought that it would make it easier for reviewers and readers to find a gene of interest, but we also acknowledge the challenge to locate the genes we highlight. We follow for R2 that reviewer's recommendation to provide some guidance for readers trying to locate a featured gene by pointing relative locations. While adding a column of numbers to already complex table seems more than what is called for, we are depositing an Excel spreadsheet of the table at the Dryad repository to facilitate searching by an interested reader for a particular gene.

• Figure 6: stats? The pink and red are hard to easily distinguish from each other. I also suggest not using red and green together for color blind readers.

With regard to the box-plots and significance testing, please see response above to an earlier recommendation. We have removed an interpretative adjective (i.e. "marked") from the description of the graph. Different symbols as well as colors are used, so we do not think that this will pose a problem for readers, even those with complete red-green color blindness. For what it’s worth, with regard to the "red" and "pink" issue, according to the figure on our displays the colors of the two symbols appear to be red and purple. They are also applied to different species and different conditions for those species.

• Figure 8: In the legend it says "... PRRs (yellow) and ISGs (gree)" which is a typo, but don't you mean blue not green anyways?

See response above to Reviewer #1's recommendation. This has been corrected.

Article and author information

Author details

  1. Ana Milovic

    Department of Microbiology & Molecular Genetics, University of California, Irvine, Irvine, United States
    Conceptualization, Data curation, Formal analysis, Investigation, Methodology, Writing – review and editing
    Competing interests
    No competing interests declared
  2. Jonathan V Duong

    Department of Microbiology & Molecular Genetics, University of California, Irvine, Irvine, United States
    Resources, Data curation, Formal analysis, Investigation, Methodology, Writing – review and editing
    Competing interests
    No competing interests declared
  3. Alan G Barbour

    Departments of Medicine, Microbiology & Molecular Genetics, and Ecology & Evolutionary Biology, University of California, Irvine, Irvine, United States
    Conceptualization, Formal analysis, Funding acquisition, Investigation, Methodology, Writing – original draft, Project administration, Writing – review and editing
    For correspondence
    Competing interests
    No competing interests declared
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-0719-5248


National Institutes of Health (AI157513)

  • Alan G Barbour

National Institutes of Health (AI136523)

  • Alan G Barbour

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.


We thank Hanjuan Shao for technical assistance, Vanessa Cook for her participation in the R. norvegicus experiment, Anthony Long for bioinformatic advice and contributions, and Brianna Craver-Hoover and Gajalakshmi Ramanathan for assistance with blood cell counts performed at U.C. Irvine. The experimental studies reported here were supported by National Institutes of Health (NIH) grants AI157513 and AI136523. The services of the Genomics Research and Technology Hub were administratively supported in part by NIH Cancer Center Support Grant P30 CA-062203 and NIH shared instrumentation grants RR-025496, OD-010794, and OD-021718.


The study was carried out in accordance with the Guide for the Care and Use of Laboratory Animals: Eighth Edition of the National Academy of Sciences, and according to ARRIVE Guidelines ( The protocols AUP-18-020 and AUP-21-007 were approved by the Institutional Animal Care and Use Committee of the University of California Irvine. For all injections the rodents were anesthetized with inhaled isoflurane. The rodents were euthanized by carbon dioxide overdose and intracardiac exsanguination at the termination of the experiment. No animals died or became moribund before the 4 hour or 12 h termination time points in the LPS experiments or before the 5 d termination point of infection study.

Senior and Reviewing Editor

  1. John W Schoggins, The University of Texas Southwestern Medical Center, United States

Version history

  1. Preprint posted: June 7, 2023 (view preprint)
  2. Sent for peer review: June 29, 2023
  3. Preprint posted: August 25, 2023 (view preprint)
  4. Preprint posted: November 22, 2023 (view preprint)
  5. Version of Record published: January 9, 2024 (version 1)

Cite all versions

You can cite all versions using the DOI This DOI represents all versions, and will always resolve to the latest one.


© 2023, Milovic et al.

This article is distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use and redistribution provided that the original author and source are credited.


  • 624
    Page views
  • 72
  • 0

Article citation count generated by polling the highest count across the following sources: Crossref, PubMed Central, Scopus.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Ana Milovic
  2. Jonathan V Duong
  3. Alan G Barbour
The infection-tolerant white-footed deermouse tempers interferon responses to endotoxin in comparison to the mouse and rat
eLife 12:RP90135.

Share this article

Further reading

    1. Immunology and Inflammation
    Anil Verma, Chase E Hawes ... Smita S Iyer
    Research Article

    CD4 T follicular helper cells (Tfh) are essential for establishing serological memory and have distinct helper attributes that impact both the quantity and quality of the antibody response. Insights into Tfh subsets that promote antibody persistence and functional capacity can critically inform vaccine design. Based on the Tfh profiles evoked by the live attenuated measles virus vaccine, renowned for its ability to establish durable humoral immunity, we investigated the potential of a Tfh1/17 recall response during the boost phase to enhance persistence of HIV-1 Envelope (Env) antibodies in rhesus macaques. Using a DNA-prime encoding gp160 antigen and Tfh polarizing cytokines (interferon protein-10 (IP-10) and interleukin-6 (IL-6)), followed by a gp140 protein boost formulated in a cationic liposome-based adjuvant (CAF01), we successfully generated germinal center (GC) Tfh1/17 cells. In contrast, a similar DNA-prime (including IP-10) followed by gp140 formulated with monophosphoryl lipid A (MPLA) +QS-21 adjuvant predominantly induced GC Tfh1 cells. While the generation of GC Tfh1/17 cells with CAF01 and GC Tfh1 cells with MPLA +QS-21 induced comparable peak Env antibodies, the latter group demonstrated significantly greater antibody concentrations at week 8 after final immunization which persisted up to 30 weeks (gp140 IgG ng/ml- MPLA; 5500; CAF01, 2155; p<0.05). Notably, interferon γ+Env-specific Tfh responses were consistently higher with gp140 in MPLA +QS-21 and positively correlated with Env antibody persistence. These findings suggest that vaccine platforms maximizing GC Tfh1 induction promote persistent Env antibodies, important for protective immunity against HIV.

    1. Cell Biology
    2. Immunology and Inflammation
    Jasper Iske, Rachid El Fatimy ... Abdallah Elkhal
    Research Article

    Septic shock is characterized by an excessive inflammatory response depicted in a cytokine storm that results from invasive bacterial, fungi, protozoa, and viral infections. Non-canonical inflammasome activation is crucial in the development of septic shock promoting pyroptosis and proinflammatory cytokine production via caspase-11 and gasdermin D (GSDMD). Here, we show that NAD+ treatment protected mice toward bacterial and lipopolysaccharide (LPS)-induced endotoxic shock by blocking the non-canonical inflammasome specifically. NAD+ administration impeded systemic IL-1β and IL-18 production and GSDMD-mediated pyroptosis of macrophages via the IFN-β/STAT-1 signaling machinery. More importantly, NAD+ administration not only improved casp-11 KO (knockout) survival but rendered wild type (WT) mice completely resistant to septic shock via the IL-10 signaling pathway that was independent from the non-canonical inflammasome. Here, we delineated a two-sided effect of NAD+ blocking septic shock through a specific inhibition of the non-canonical inflammasome and promoting immune homeostasis via IL-10, underscoring its unique therapeutic potential.